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Over the last decade, there have been remarkable technological advances 
that have revitalized the age old idea that biology is first and foremost an 
observational science. Nowhere has this Galisonian ideal of scientific 
discovery been more realized than in the study of cell biology and signaling 
processes that govern a cell’s functionalities. Imaging techniques, beginning 
with the advent of genetically encoded fluorescent proteins, to the more 
recent single molecule imaging techniques that allow for observation of 
biological processes at resolutions below the diffraction limit of light, have 
given scientists the ability to gaze deep into living cells and discern 
molecular processes. These technologies have more than ever illustrated 
that the cell is not merely an aqueous mixture of proteins and molecules 
enclosed in a lipid bilayer membrane, but rather a tightly organized structure 
where signaling processes can be highly anisotropic. Detailed observations 
of cellular processes, afforded by these new imaging techniques,  have 
given rise to a host of new questions regarding the orchestrating 
mechanisms underlying complex signaling events, the answers to which 
require precise perturbations that induce very specific and controlled 
changes.  
 
 
 
Given the complex spatial organization of the cell cytoplasm and the strict 
temporal order of molecular signaling events, traditional experimental 
methods to probe and dissect cellular signal transduction suffer from major 
drawbacks. Light-gated protein modules and other molecules offer both 
spatial and temporal control of proteins’ subcellular localization and 
functions. Recent years have witnessed a rapid expansion of these 
technologies which have already begun to produce spectacular advances in 
the understanding of cell biology, animal physiology, and behavior.  
This thesis is written in two parts. The first part, consisting of one chapter, 
gives an overview of the current light-gated technologies to control protein 
functions. The second part which is divided in two separate chapters 
describes the development and testing of two novel technologies that make 
use of light to control cell surface receptors activation in a spatiotemporal 
specific manner. These chapters will also discuss the potential applications 
of these technologies to address outstanding questions in cellular signal 
transduction.  
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CHAPTER1: A review of current methodologies to control protein functions 
with light.   
Proteins are macromolecules that are the workhorse behind most cellular 
processes. They have a wide range of functions from providing structural 
support to enzymatic reactions and catalysis that support a cell’s survival 
and propagation. In the cellular milieu, a protein’s function is tightly regulated 
by complex mechanisms that involve cascades of regulators and effectors 
interacting in a precise spatial and temporal manner.  In order to understand 
protein functions and in effect biological processes at a molecular level, 
precise control of protein activity is important. Light is an ideal external 
perturbation stimulus as light irradiation can be tuned in a spatial and 
temporal fashion. In recent years, there have been numerous light-gated 
technologies to control protein function. These technologies fit into three 
broad groups of approaches (1) Photocaged Small Molecules and Protein 
Ligands, (2) Chemical and Genetic Hybrids and (3) Genetically Encodable 
Light Responsive Proteins. The distinguishing factor between these 
categories is the type chemistry involved in the preparation of each 
technology. Photocaged small molecules and protein ligand approaches 
employ organic chemistry to covalently modify the relevant elements with 
photosensitive moieties. Chemical and genetic hybrid approaches combine 
genetic engineering and cellular expression of effector proteins. Protein 
function then is controlled with photo-sensitive elements which can be 
installed onto effector proteins in situ using biorthogonal chemistry, or 
supplied exogenously in the forms of synthetic photo-caged small molecules 
that activate or inhibit the effector protein. Finally, genetically encodable light 
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responsive proteins approaches are those that do not rely on any chemical 
modification and the light sensing elements are genetically encoded. In this 
chapter, I will attempt to give a broad overview of the technologies in each 
category.  
1.1 Photocaged small molecules and ligands. 
1.1.1 Photocaged small molecules. 
Some of the earliest attempts to control protein function and cell signaling 
with light involved chemically installing on small molecules, at positions that 
are critical to the molecules’ bioactivity, photo labile groups. This strategy 
relies on the chemical accessibility of the small molecules to be conjugated. 
As small molecules are often soluble in aqueous solution and can diffuse 
across the cell membrane, caged compounds that have known effects on 
effector protein function can provide a means to temporally, and to lesser 
extent spatially due to free diffusion, control signaling events. Photocaging 
was not a novel concept in chemistry as caging moieties had been 
extensively used as protecting groups during organic synthesis. However, it 
was not until biologically active molecules were caged that idea of using 
photocaging as a way to spatiotemporally control signaling events gain 
appreciation as a useful experimental tool.  
The earliest small bioactive molecules that were caged were photocaged 
analogs of the  metabolite ATP1 and the secondary messenger cAMP2 , 
which were synthesized in the late 1970s (Figure 1.1). Since then caged 
analogs of a wide range of compounds from hormones to cell permeable ion 
chelators to enzyme inhibitors and neurotransmitters have been synthesized 
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and used for biological experiments3. These caged compounds have 
afforded biologists the ability to control a variety of cellular functions using 
light. Indeed, caged neuro-transmitters have been proven to be very useful 
in the field of neuroscience4. Live brain slices, for example, once immersed 
in caged neurotransmitters, such as caged glutamate, can be stimulated in a 
spatiotemporally specific manner with light to emulate complex neural 
activity6,7. Caged second messenger molecules like cAMP and diacylglycerol 
have successfully been used to activate signaling circuits in cell biology 
experiments to study growth cone turning 8 and the activation of kinase 
dependent signal transduction9 respectively.  
Figure 1.1: Caged ATP and cAMP were two of the earliest photo-
sensitive biologically active compounds to be synthesized. Both 
compounds were modified with the UV-liable ortho-nitrobenzyl group. The 
synthesis and characterization of the ortho-nitrobenzyl analog of ATP in 
1978 was where the term “caged” was first coined by the chemists involved1. 
Caged ATP is still commercially available today and applications of this 
compound are extensive5.  
1.1.2 Photocaged protein ligands. 
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Cell surface receptors constitute a large family of proteins that carry out the 
important function of sensing cues from the extracellular environment and 
translating those into cellular processes that affect function, growth and 
survival of the cell. Since many cell surface receptors bind to protein ligands, 
photo-caged protein ligands allow for the control of cell surface receptor 
activation with light. Furthermore, as ligands can be immobilized on solid 
surfaces, precise spatial control of receptor activation can be achieved as  
 
Figure 1.2: Photoactivation system to trigger TCR activation by UV light. 
(A) Caging strategy for the MCC peptide. A NPE group is attached to the 
lysine residue shown in red to inactivate the peptide. Subsequent UV 
irradiation cleaves NPE off the lysine and restores its native form (green). (B) 
Schematic graph of the photoactivation process. The large hydrophobic NPE 
group attached to the MCC peptide prevents the TCR from binding to the 
peptide MHC complex until it is cleaved by UV light. Figure adapted from 
Huse M., Immunity, 2007. 
tethered decaged ligands cannot diffuse away from the local region of de-
caging irradiation. Unlike small molecules, however, protein ligands present 
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unique challenges in terms of chemical modification. First of all, protein 
ligands are often large macromolecules. Ligands such as cytokines and 
growth factors can be tens of kDa in size and consist of hundreds of amino 
acids as is the case with the hormone Erythropoietin. Chemical syntheses of 
such large molecule are labor intensive and often low in yield. More 
challenging than the synthetic hurdle is the issue of where to attach the 
caging group. Protein ligands, unlike small molecules, are complicated 
molecules with secondary and tertiary structures whose structure-activity 
relationships are often unclear. This makes the task of engineering caged 
protein ligands whose activities are masked by a simple caging group 
difficult. Given said challenges, the development of caged proteins via direct 
chemical synthesis has lagged behind that of caged small molecules.  
To date, the use of a caged peptide-major histocompatibility complex 
(pMHC) remains one of the more successful applications of photo-caged 
ligands. T-cell function is potently regulated by the activation of T-cell 
receptor (TCR) by the pMHC. One of the defining features of the pMHC 
complex is the presence of a short strand of peptide (which might be self or 
non-self in nature) that is “presented” by the MHC protein to the TCR. This 
particular composition allows for a caging strategy where a photosensitive 
group can be installed on an amino acid critical for TCR binding and 
activation (Figure 1.2). An MHC protein complexed with a caged antigenic 
peptide is able to control T-cell activation in a light dependent manner. When 
tethered onto solid surfaces, recombinant photo-caged pMHC can be used 
to control TCR activation with great precision10,11. This approach has been 
successfully used to perturb and delineate complex spatial and temporal 
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signal transduction downstream of TCR activation12–14 as well as the 
inhibitory receptor KIR2DL2 involved in NK cells activation15. Clinically more 
relevant, caged pMHC forms the basis of conditional MHC technology16 
which is instrumental in transforming the synthesis of MHC tetramers into a 
more efficient process. Efficient recombinant MHC folding requires the 
presence of a strong binding target peptide sequence. MHC folding in the 
presence of a high affinity caged peptide allows for high yield production of 
pMHC complexes. The correctly folded pMHC containing the caged target 
peptide can then be irradiated in the presence of a high concentration of the 
target agonist peptide of choice. The caged peptide, upon UV-induced 
degradation diffuses away from the MHC binding cleft and is replaced by the 
target agonist peptide present in excess. This elegant technology has been 
used extensively to discover epitopes for important human diseases and to 
monitor the immune system in clinical settings17.  
Advances in peptide chemistry such as native chemical ligation and 
expressed protein ligation have made the synthesis and engineering of large 
polypeptides easier. Chemokines are generally small proteins of less than 
100 amino acids and therefore are synthetically accessible via solid phase 
peptide synthesis with the aid of native chemical ligation when needed. 
Furthermore, chemokines are well-characterized in terms of their structures 
and functions. The N-termini of most chemokines, for instance, are 
unstructured and critical for chemokine agonist activity 18. By installing a 
photosensitive moiety on critical amino acids in the N-termini of chemokines, 
one can control their activity with light. Chapter 2 of this thesis describes a 
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photocaged SDF1α chemokine and the application of this caged protein 
ligand in the study of chemokine receptor signaling.  
1.1.3 Chemical and genetic hybrids: 
The direct chemical modification of bioactive molecules or polypeptide 
ligands with photosensitive moieties restricts the applicability of light-gated 
technology to the targets of these small molecules and protein ligands. By 
combining genetic expression and/or engineering with synthetic 
photoactivatable elements, hybrid approaches can be developed that 
expand the range of light-gated technologies. There are two general 
strategies to create hybrid technologies to control protein function with light: 
cis and trans-actuator (Figure 1.3).  
Conceptually, trans-actuator technologies are simpler to design and 
implement. Trans-actuator hybrid technologies rely on the expression of 
effector proteins with domains responsive to chemical elements whose 
activity can be tuned with light. This strategy was first employed to generate 
approaches to control gene expression with great spatiotemporal precision. 
Transgene-based expression platforms, such as ecdysone19 and 
doxycycline-based20 systems, are great tools to control gene expression with 
the use of an exogenous agent. These systems make use of synthetic small 
molecules whose targets are gene-responsive elements able to drive gene 
expression. By caging the synthetic molecules, gene-expression can be 
controlled with light. Indeed, caged versions of ecdysone21 and doxycycline22 
have been used to great effect to control gene expression in various 
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organisms (mouse embryos and Xenopus laevis tadpoles) with great 
precision by local irradiation with UV light or two-photon uncaging.  
Figure 1.3: Trans and cis-actuator technology. (A) Trans-actuator 
technologies rely on expression of proteins containing domains responsive 
to photo-caged small molecules or elements supplied exogenously. (B) Cis-
actuator technologies rely on the light-responsive elements being conjugated 
directly onto the proteins upon which they are to exert their light-dependent 
activity. Figure adapted from Gautier,A., et al., Nature Chemical Biology, 
2014 
Aside from transcriptional control of protein expression, trans- actuator 
technologies have also been developed to control protein localization and 
protein-protein interaction. A generalizable strategy to control protein-protein 
interaction utilizes a caged rapamycin molecule to control the 
heterodimerization of proteins that are conjugated to FK-506 binding protein 
(FKBP) and FKBP-rapamycin binding protein (FRB.) By localizing FRB to the 
A 
B 
9 
 
plasma membrane and conjugating the GTPase Rac to FKBP, light 
controlled membrane recruitment of Rac and subsequent actin 
polymerization was achieved23. The FKBP domain can also serve as an 
inhibitory module and when conjugated to a kinase enables the control 
kinase activity with light24. A closely related technology to direct protein 
localization with light makes use of caged 4-hydroxyl-tamoxifen or cyclofen 
and the ligand binding domain of estrogen receptor (ERT2). In the absence of 
ligand, ERT2 is sequestered by its cytoplasmic chaperone heat-shock protein 
(HSP) in a complex.  This complex dissociates upon the binding of 4-
hydroxyl-tamoxifen or cyclofen to ERT2. By fusing effector proteins to ERT2, 
lighted technologies have been developed to control nuclear protein 
localization25,26 and DNA recombination in mammalian cells27 with light.  
Providing even more degrees of control, trans-actuator technologies that 
make use of plant-based phytochrome B (PHYB) and phytochrome 
interacting factor (PIF) have the added advantage of reversibility. Discovered 
as the protein that controls seedling stem elongation in Arabidopsis thaliana, 
PHYB, when expressed and bound to the chromophore PCB, is activated by 
red light (650nm) and inactivated by infrared light (750 nm)28. PHYB, in its 
PCB bound state, undergoes a conformational change when activated by 
red light and binds to PIF within seconds29. Taking advantage of this light 
dependent reversible dimerizing property, the PHYB-PIF system has been 
used to develop light-gated modules to control a wide range of signaling 
events. The general strategy entails fusing an effector protein to the PHYB 
subunit and a corresponding regulatory element to the PIF subunit. After 
supplying the cell with PCB, light can be used to force interaction between 
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an effector protein and its regulatory element. For example, the PHYB-PIF 
system was used to control actin polymerization by forcing interaction 
between the small GTPases Rac30, CDC4230, Rho30 and the corresponding 
GEFs. Activation of the lipid kinase PI3K was controlled with light by forcing 
interaction between the kinase catalytic domain and a membrane bound 
activating domain of a PI3K regulatory protein31.  
Cis- actuator technologies, which rely on the photosensitive elements to be 
conjugated onto the protein upon which they are to exert caging function, are 
technically more challenging. The caging element has to be installed onto 
the protein of interest at a specific location. Some of the most successful cis-
actuator platforms have been those developed for the control of ion channels 
(Figure 1.4). The general strategy makes use of a photo-isomerizable 
azobenzene moiety conjugated to a bulky and charged quaternary 
ammonium group. This moiety adopts a cis configuration when irradiated 
with high energy light (380nm) and a trans configuration when irradiated with 
lower energy light (500 nm.) When tethered just above the pore of an ion 
channel, the trans configuration, which is 7 angstrom longer than the 
collapsed cis configuration, can extend over the pore and blocks ion 
exchange with the positively charged and bulky quaternary ammonium 
group. In practice, the modification of ion channels in vitro as well as in live 
cells is carried out with a maleimide conjugated azobenzene moiety. The 
maleimide forms a covalent bond with thiol group on the side chain of a 
solvent exposed cysteine residue which has to be introduced into the ion 
channel of interest as a point mutation. Using this approach, a light gated K+ 
channel was generated32. Light-activated ionotropic glutamate receptor33 
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and potassium-selective glutamate receptor34 were also developed by 
switching out the quaternary ammonium group with a glutamate analog.  
The ease by which light-gated ion channels were modified in situ using a 
maleimide warhead is an exception to the often complicated problem of 
chemical derivatization of proteins. Codon suppression technology, which 
allows for the introduction of unnatural amino acids into proteins with 
engineered tRNAs, has largely circumvented the technical challenges 
involved when modifying proteins with photosensitive elements in a site-
specific fashion. Indeed, codon suppression technology has been used to 
develop light-gated tools to control a range of biological processes. For 
example, methods to control protein localization35 and gene expression36 
were developed by replacing critical lysine residues in the nuclear targeting 
sequence (NLS) of effector proteins or in the promoter binding domain of 
polymerases respectively with photoactivatable lysine analogs. Kinase signal 
transduction37 and cysteine protease activity38 were similarly controlled by 
replacing, respectively, phosphorylation target tyrosines and catalytic 
cysteine residues with light-sensitive analogs. As the codon suppression 
technology continues to improve to allow for the incorporation of unnatural 
amino acids into effector proteins at the organism level, light-gated 
technologies are set to expand in the types of biological processes that could 
be modulated with spatial and temporal specificities.  
12 
 
Figure 1.4  A light-gated ion channel as an example of a cis-actuator 
technology. (A) Chemical structure of the photo-isomerizable azobenzene. 
The maleimide (MAL) “warheard” allows for covalent modification at cysteine 
residues that have been introduced via point mutation. The azobenzene 
(AZO) is the light responsive element that photo-switches between trans and 
cis conformation whose difference in length provides the blocking or caging 
of the ion channel. The quaternary ammonium (QA) group, which is 
interchangeable with other functional groups depending on the target ion 
channel, is in this case specifically chosen for its positive charge to keep out 
cations. (B) Caged potassium channel in action. Figure adapted from 
Banghart, M. et al., Nature Neuroscience, 2004. 
13 
 
1.2  Genetically Encodable Light Responsive Proteins 
The last category of technology includes some of the most recent advances 
in the use of light to control protein function. These technologies rely on 
genetically encoded protein actuators that change conformation and become 
activated in response to light. By repurposing these proteins either through 
engineering or hi-jacking their natural function by expressing them in non-
native cells or organisms, genetically encoded light-sensitive proteins have 
the distinct advantage of being a single component system, eliminating the 
need to exogenously supply light responsive molecules. This single 
component property is important particularly for organism-level control of 
protein function where the exogenous delivery of a synthetic photo-sensitive 
cofactor might be technically challenging or physiologically traumatic.  
The earliest genetically encoded light-gated technologies were developed 
from opsins which are photoreceptors that sense light as a stimulus. These 
proteins require the presence of a vitamin-A related cofactor called retinal to 
function. In their retinal-bound forms, opsins are referred to as rhodopsins. 
Because retinal is present at sufficient concentration in most mammalian 
tissues, opsin proteins can function when expressed in mammalian cells 
without the need to supply the co-factor39. There are two broad families of 
opsins: microbial opsins (type I) and animal opsins (type II). The two families 
of proteins, which share very little sequence homology between their 
members, all encode 7-transmembrane receptors. Microbial opsins which 
control a wide range of functions in bacteria and fungi have been adapted to 
control neuronal activity in mammalian cells and whole animals. For 
14 
 
example, bacteriorhodopsin, which is a light sensitive proton pumps, 
halorhopsin, which is a light-sensitive chloride ion pump and 
chanelrhodopsin, which lets cations across the membrane in response to 
light, have all been expressed in neurons and whole brains. They have 
enabled researchers to, in a light dependent manner, hyperpolarize neurons 
and control neurological activities40,41. These technologies have led to 
unprecedented new understandings of neuronal circuitry and cognition42. 
They have also been adapted for the control of cardiac functions43 using light 
and for tracking stem cell development44.   
Animal opsins, which are predominantly G-protein coupled receptors 
(GPCRs), have been the subjects of intense structural studies. Such efforts 
and the resulting knowledge have allowed for the engineering of functional 
chimeric GPCRs where the extracellular and transmembrane domains of 
animal opsins are fused to the intracellular domain another GPCR. Such 
chimeras, referred to as OptoXR42, are light-sensitive receptors whose 
activation can be controlled with great precision (Figure 1.5). For example, 
bovine rhodopsin has been fused with β-adrenergic, α-adrenergic and 
serotonin (5-hydroxytryptamine (5-HT) receptors to create chimeric GPCRs 
that when expressed in the brain allow for the control of animal behaviors in 
a light-dependent manner45. Recently, by fusing bovine rhodopsin to the 
chemokine receptor CXCR4, a photoactivatable chemokine receptor was 
developed that permits for light-gated control of chemotaxis in vitro as well 
as recruitment of lymphocytes to tumor sites in a mouse using light46. 
GPCRs, as the largest and most diverse family of cell surface receptors, 
control numerous critical physiological processes ranging from sensory 
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functions, to the regulation of the immune system to cancer pathogenesis. 
That OptoXR is an elegant and effective strategy for light-gated control this 
family of receptors is scientifically exciting and clinically relevant.  
Also from a bacterial source, photoactivatable adenylyl cyclases (PACs), 
which are light sensitive receptors that transduce cAMP signaling to control 
photoavoidance in soil bacteria47, have successfully been used to control 
cAMP signaling in a light dependent manner in mammalian cells48. PACs, 
similar to opsins, make use of a co-factor, flavin adenine dinucleotide (FAD), 
that is ubiquitous in the cellular environment, and therefore function as single 
component light-gated platforms. Unlike opsins however, PACs suffer from 
high background activity in the dark as well as poor expression and in vivo 
folding48 and so therefore have not been used widely.  
Photo-sensitive receptors, as discussed, are great tools to engage the full 
complement of signal transduction involved in regulating a particular cellular 
process. Naturally occurring light-responsive cytoplasmic proteins have also 
played important roles as building blocks for light-gated technologies. As 
reviewed in 1.2, PHYB-PIF based technologies have enabled researchers to 
control of protein functions via light-inducible dimerization. The drawback of 
the PHYB-PIF platform is the need to supply the cofactor PCB by either 
directly supplementing the cell culture medium or expressing the relevant 
enzymes to synthesize PCB in the cell of interest. Fortunately, there are 
other photo-sensitive cytoplasmic proteins derived from plants and coral 
such as cryptochrome 2 (CRY2), light oxygen-voltage (LOV) protein 
domains, the fluorescent protein dronpa and cytoplasmic UV-B detecting 
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receptor (UVR8), that do not require cofactors. These proteins form the 
foundation upon which numerous light-gated technologies have been 
developed.  
Figure 1.5 Chimeric GPCRs engineered from light-sensing rhodopsins 
are genetically encodable light-gated technologies. Decades of structural 
studies of mammalian opsins have provided detailed understanding of the 
allosteric circuits underlying the light-sensing property of these GPCRs. This 
knowledge enables the engineering of functional chimeric receptors 
containing the extracellular light-sensing domain of rhodopsin and the 
intracellular signal transduction domains of other GPCRs. These light-
responsive GPCRs termed OptoXRs provide researchers with 
unprecedented spatiotemporal control of the most diverse and functionally 
important class of cell surface receptors in eukaryotic organisms. Figure 
adapted from Airan, RD., et al., Nature (2009). 
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Cryptochrome 2, expressed in Arabidopsis thaliana, is a blue-light sensing 
protein that uses the ubiquitously expressed flavin as the photon-sensing 
chromophore. Upon illumination, CRY2 homo-oligomerizes and binds to its 
cognate partner, the cryptochrome-interacting basic helix-loop-helix domain 
(CIB1) within seconds49. When illumination is withdrawn, CRY2 reverts back 
its monomeric and inactivated form within 5-10 minutes50. This light-sensitive 
oligomerization property has been exploited to control a wide of range of 
protein functions and cellular processes. When the CRY2/CIB1 proteins are 
conjugated to split subunits of a transcription activator protein (GAL4) or a 
DNA recombinase (CRE), light-induced oligomerization of the CRY2/CIB1 
complex provides a means to control gene expression and DNA 
recombination events respectively51. Using a slightly different strategy than 
the split effector proteins approach, by fusing the CRY2 protein to either a 
customizable DNA promoter binding protein TALE or an inactivated 
endonuclease Cas9; and the CIB1 protein to a transcription activator, 
remarkable optical control of mammalian endogenous transcription and 
epigenetic states has been achieved40. Not limited to just gene expression 
control, the CRY2-CIB1 system has been used to develop methods to 
control other effector protein functions via light-inducible clustering. After 
conjugating CRY2 to the multimeric protein CaMKIIα and CIB1 to an effector 
protein, illumination with blue light causes cytoplasmic clustering of the 
effector protein and as a result modulates its activity. This strategy was 
employed to control with light the activity of Vav, a Rho-GTPase GEF that 
controls membrane ruffling, and the lipid kinase PI3K52. Finally, the protein 
CRY2 alone, which as discussed, homodimerizes upon blue light irradiation, 
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has been used to control cell surface receptors activation via optically 
controlled dimerization53,54.  
Even more extensively used in light-gated technologies than CRY2, is the 
light-oxygen-voltage (LOV) domain family of proteins, which was first 
discovered to mediate phototropism in plants. LOV domains are the photo-
reactive modules that sense blue light and convert this stimulus into a myriad 
of signaling responses55. Proteins that contain LOV domains are diverse in 
structure and function and are present in plants, bacteria and fungi. LOV 
domains themselves are therefore also very structurally diverse. There are 
however a few common features tying the family together. LOV domains 
tend to be around one-hundred amino acid long, forming a Period-ARNT-
Singleminded (PAS) domain that binds a flavin chromophore56. There is also 
the presence of a consensus GXNCRFLQ motif57. Upon blue-light irradiation, 
LOV domains form a covalent linkage with the bound flavin cofactors, which 
leads to a series of allosteric conformational changes that regulate the 
parent proteins’ function (Figure 1.6). This process is reversible in the dark 
with kinetics that range from minutes to days that can be tunable via 
mutagenesis58. The precise mechanism and conformational changes upon 
irradiation differ subtly but significantly among the different LOV domains. 
This diversity has provided researchers with a rich toolkit from which to build 
light-gated technologies to control protein functions in a variety of settings. 
Generally, there are two main strategies to create light-gated technologies 
using LOV domains. The first strategy involves conjugating an effector 
protein to a LOV domain via a helical linker which acts an inhibitory element 
to the protein’s function. Conformational changes in the LOV domain upon 
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blue-light irradiation release the inhibitory linker and restore the function of 
the effector protein. The second strategy, which is more frequently used, 
exploits blue-light induced homo-dimerization of certain LOV domains. 
Similar to the CRY2-CIB1 or PHYB-PIF based technologies; light-gated 
technologies can be created by fusing split effector proteins or complexes to 
LOV domains (Figure 1.7).  
Currently LOV-domain based technologies use one of five LOV domains 
which include a LOV domain of phototrophin 1 in the plant Avena sativa  
called AsLOV259, a photoreceptor found in Neurospora crassa that regulates 
circadian rhythm called vivid (VVD)60, a component of the Bacillus sublitis 
stressosome (YtvA)61, an output component responsible for the transition to 
flowering called flavin-binding, kelch repeat, F-box 1 (FKF1)62, and a LOV-
domain containing transcription factor present in Eyrothobacter litoralis 
called EL22263.  
More recently, the protein dronpa, which was first identified in the coral 
Pectiniidae, has been used to develop light-gated technologies. Classically 
known as a green fluorescent protein with great photo-stability and 
brightness that is reversibly photo-activated upon irradiation64, dronpa also 
undergoes light-driven dimerization when irradiated with a 390 nm that can 
be reversed with a 490 nm light 65. Capitalizing on this reversible 
dimerization property, one strategy to create light-gated technologies 
involves fusing one copy of dronpa each to the amino and carboxyl termini of 
an effector protein. When irradiated with 390 nm light dronpa dimerizes and 
inhibits the effector protein function by morphing its conformation. Upon 
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Figure 1.6 LOV domain containing proteins belong to a large and 
diverse family of light-sensing proteins that use flavin mononucleotide 
(FMN) as the photosensitive chromophore. (A) Structure of an “activated” 
LOV2 domain. The (FMN) cofactor in gray is shown to be in covalent 
complex with C966. (B) A schematic showing the covalent interaction 
between C966 and FMN upon blue light irradiation. (C) The FMN-binding 
pocket of the LOV2 domain. Residues that interact with the FMN cofactor 
are shown in either orange for the illuminated state or in grey for the dark 
state. Key residues of the highly conserved motif GXNCRFLQ shared among 
LOV domains are labeled. Figure adapted from Herrou, J., et al., Nature 
Review Microbiology (2011) 
 
irradiation at 490 nm, the dronpa dimer is disrupted and the target protein’s  
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function is restored. Using this strategy, optical control of cytoskeletal 
dynamics and protease function were achieved with great spatial and 
temporal resolution66.  
 
Figure 1.7 Two general strategies are employed to create light-gated 
technologies to control protein function using LOV domains. (A) A LOV 
domain and an effector protein are conjugated via a helical linker which acts 
an inhibitory element to the effector protein’s function. Conformational 
changes in the LOV domain upon blue-light irradiation release the inhibitory 
linker and restore the function of the effector protein. (B) Some LOV domains 
undergo light induced dimerization. Light-gated control of an effector protein 
can be achieved by conjugating the split effector protein to LOV domains. 
Figure adapted from Herrou, J., et al., Nature Review Microbiology (2011) 
Finally, as the most recent addition to the rapidly expanding family of photo-
sensitive proteins isolated from plants, UVR8 is unique in that it detects and 
Split effector 
Split effector 
A B 
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responds to UV-B light67,68. In its “inactive” form UVR8 exists as a dimer and 
upon UV-B irradiation, within seconds, monomerizes. The monomers can 
themselves revert to dimers albeit with a slow kinetics on the time scale of 
hours69. This property has been exploited to control protein secretion in 
mammalian cells. The strategy involves conjugating multiple copies of UVR8 
to a protein that would normally be secreted. Without UV-B irradiation, the 
effector protein, driven by UVR8’s default state of dimerization, aggregates 
and cannot be secreted. Upon irradiation, the monomerization of the 
attached UVR8 allows for the detachment of the effector protein and 
synchronized light-controlled secretion is achieved70. 
1.3 Discussion 
It is clear that light-gated technologies have provided scientists with 
remarkable tools to answer important questions across biological disciplines. 
Neurobiologists have seen the impact of these technological advances, 
termed optogenetics by researchers in the field, in the most significant way. 
Optogenetics has allowed for unprecendented perturbation and control of 
processes such as memory formation, depression and cognitive functions 
previously deemed impossible to manipulate experimentally. The advent of 
optogenetics played no small part in the recent multimillion dollar BRAIN 
initiative by the US government to map and understand the brain better. A 
few reasons underscore the success of optogenetics in neurobiology. 
Opsins, which were used to develop optogenetics, have relatively rapid 
photocycles in the range of 10-20 ms39 which allows for sufficient temporal 
control of neuron depolarization. From the spatial resolution perspective, 
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optical control of neuronal circuits and behaviors rests on the control of 
groups of cells rather individual cells or subcellular compartments of a 
neuron. This, coupled with advances in viral transduction, enables spatial 
control of neuronal activity with sufficient experimental resolution. Lastly, the 
open source approach of the original investigators, who started the field of 
neuro-optogenetics, to disseminate the techniques has played an important 
role in the wide adoption and usage of the technology among 
neurobiologists.  
Cell biology and the study of signaling pathways that underlie cellular 
processes in response to stimuli from the environment stand next to gain in 
the same way that neuroscience has done from light-gated technologies. 
There are however several outstanding issues. Most importantly, 
perturbations to dissect signaling in cell biology require subcellular spatial 
resolution. With recent advances in two-photon microscopy and other optical 
instrumentation, it is possible to focus light to illuminate geometrically 
defined regions inside the cell. However, the practical spatial resolution of a 
photoactivatable actuator will match the resolution provided by the focused 
light source only if the photo-activated element does not diffuse in the cell in 
the timescale that researchers would like to observe certain signaling 
processes. This is particularly problematic for caged small molecules whose 
spatial specificity is limited by the rate of free diffusion in the cellular milieu. 
Genetically encoded photosensitive proteins also suffer from the same issue 
though in some cases there are effective, but technically challenging, 
workarounds. Systems that use the PHYB-PIF complex, for instance, to 
optically control protein function have the advantage of full-reversibility that 
24 
 
allows for precise spatial control of activation. As PHYB-PIF is rapidly 
activated by blue light and just as rapidly inactivated by far-red light, by 
superimposing localized red light over a uniform field of far red light, 
researchers with significant technological capability and instrumentation at 
their disposal, can achieve spatial control. It is worth noting that this strategy 
only works for the PHYB-PIF system. The most frequently used photo-
sensitive proteins such CRY2 and LOV domains once activated undergo a 
much slower (5-10 seconds for CRY2 and 10 to 10000 seconds for LOV 
domains58) thermal reversion to the inactive states. Precise spatial control 
therefore remains an issue to be addressed.  
As aforementioned in 1.1.2, photo-caged extracellular ligands when 
immobilized on solid surfaces can provide precise spatial control of cell 
surface receptor activation as the tethered ligands, once decaged locally by 
focused irradiation, cannot diffuse away. Our laboratory pioneered two of 
such techniques to activate the TCR and the inhibitory NK cell receptor 
KIR2DL2. When coupled with high magnification live cell imaging, these 
tethered extracellular ligands have enabled very precise spatial stimulation 
of immune receptors. The TCR and KIR2DL2 both recognize short agonist 
peptides which are bound and “presented” by larger major histocompatibility 
complex (MHC) proteins. The design and synthesis of photo-caged ligands 
for these receptors therefore involve modifying short peptide sequences, 
which can be readily synthesized via solid phase peptide synthesis, with 
caging groups on residues known to be critical to the peptides’ agonist 
activity. Chapter 2 of this thesis describes an effort to extend this caged 
ligand strategy beyond the caging of short polypeptide chains. It describes 
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the design and synthesis of a full-length caged chemokine protein that allows 
for the precise spatial and temporal control of chemokine receptor signaling. 
Chapter 3 gives an account of the development of a “universal” photo-caged 
extracellular ligand able to control with high spatial precision the activation of 
a range of cell surface receptors.  
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CHAPTER 2: Development of a photoactivatable CXLC12/SDF1α for the 
study of CXCR4 signaling in lymphocytes.  
2.1 INTRODUCTION: 
2.1.1 Lymphocyte migration and motility 
T-lymphocytes or T-cells are a critical component of the adaptive immune 
system. T-cells possess highly agile migratory capabilities which are 
essential to their development and function as effectors in the clearing of 
infections71. Differentiated from hematopoietic stem cells in the bone 
marrow, T-cell progenitors migrate out of the bone marrow into the thymus 
for extensive selection and maturation72. Mature yet naïve T-cells only 
respond to infections when their T-cell receptors (TCR) recognize antigens. 
Since T-cells develop in the primary lymphoid organs, namely the bone 
marrow and the thymus gland, and antigen present cells (APCs) which 
detect and present antigens for TCR engagement reside in secondary 
lymphoid organs (lymph nodes) at different locations throughout the body, T-
cell migration to and from lymphoid organs is critical to their function73. After 
activation, antigen-specific T-cells have to migrate and scan the body to find 
sites of inflammation and disease to perform their effector functions71. Once 
infections have been cleared, some memory T-cells migrate or home to 
specific regions of the tissue in order to mount a rapid response in case of 
future repeated infections74.  
T-cell migration is associated with a specific migratory morphology (Figure 
2.1).  This structural configuration, which resembles a hand-mirror, consists 
of a broad, actin-rich lamellipodium at the leading edge followed by a 
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cylindrical uropod at the rear. T-cell migration uses a mechanism mirrored by 
the amoeba Dictyostelium discoideum. Four distinct steps coordinate the 
forward movement of the cells: actin dynamics drive the formation of 
protruding pseudopods, the protruding membrane and associated receptors 
sense the extracellular environment by interacting with ligands and 
substrates, myosin-based contractibility squeezes the cell body in the mid-
region, and the rear end of the cell moves forward propelling directional 
movement71. T-cell migration is a special kind of cell movement compared to 
mesenchymal or epithelial migration. First of all, T-cell migration is fast with 
speed up to 30 μm/min75. T-cell migration also does not promote the 
formation of strong adhesion to surrounding tissues. These two unique 
properties make T-cell migration one of the most dynamic forms of cell 
migration.   
2.1.2 Chemokines and their receptors 
T-cell migration is highly directional and is regulated by chemokine receptors 
and chemokine ligands. Chemokines compose of a family of small, di-
sulfide-linked proteins that are produced and secreted by endothelial and 
epithelial cells as well as leukocytes76. Chemokines transmit signal by 
engaging specific G-protein coupled receptors (GPCRs). Different tissues 
express different sets of chemokines which help differentiate populations of 
T-cells that migrate to or get “recruited” to particular body sites. Chemokines 
can be either inflammatory or homeostatic77. Inflammatory chemokines, 
which are produced and secreted during pathological conditions such as 
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bacterial or viral infection and malignant tumor development, help recruit 
immune cells to sites of disease. 
 
 
 
 
Figure 2.1 Immunocytochemical staining of F-actin (in red) of a migrating 
primary mouse T-cell. The anterior-posterior axis is clearly marked by the 
differential accumulation of F-actin in the protruding lamellipodia at the front 
and the stalk-like uropod structure at the back.  
Inflammatory chemokines, which are produced and secreted during 
pathological conditions such as bacterial or viral infection and malignant 
tumor development, help recruit immune cells to sites of disease. 
Homeostatic chemokines are mainly found in lymphoid organs and help 
maintain leukocyte homeostasis and development in these organs77. Aside 
from functional distinctions, four subtypes of chemokines based on structural 
features have also been categorized. C, CC, CXC and CX3C denote the 
number and spacing of cysteine residues in the amino-terminal region of the 
chemokine. All of the subtypes except for the CX3C family, which has a 
transmembrane and cytoplasmic domain, are secreted proteins76. 
Chemokines activate their receptors in a two-step mechanism18. First the 
globular portion of the chemokine binds to the receptor. Then, the N-terminal 
tail of the chemokine induces a conformational change in the receptor’s 
Uropod 
F-actin rich  
leading edge 
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transmembrane helices (Figure 2.2). This activates the associated G-
coupled proteins, leading to PI3K signaling, calcium flux, cytoskeletal 
remodeling, and the enhancement of integrin-mediated adhesion78. These 
and other events drive the acquisition of hand-mirror morphology.  
2.1.3 Polarization of cytoskeletal and signaling scaffolds downstream of 
chemokine receptor activation in T-cells. 
The binding of chemokines to chemokine receptors triggers dramatic 
signaling and morphological changes in T-cells. At rest, T-cells show a 
symmetrical cell body that, upon exposure to a chemotactic agent transforms 
into a highly polarized migratory morphology within minutes. At the top of the 
signal transduction cascade is the dissociation of the heterotrimeric G-
proteins consisting of αβγ subunits from the chemokine receptor upon ligand 
binding. Critical chemotactic signal transduction is then carried out by the 
Gβγ dimer which activates two major signaling circuits, phospholipase C and 
PI3K, initiating downstream signaling cascades79. At the bottom of these 
signaling cascades are highly compartmentalized signaling complexes that 
define and segregate the cell body into distinct regions. For instance, at the 
leading edge highly dynamic actin polymerization supports a protruding 
lamellipodia. Such cytoskeletal dynamics is driven by the Rho-GTPase Rac. 
The Rac-GEF DOCK2 has been shown to be an important regulator of this 
process78.  In the mid-region, actomyosin signaling drives contraction the 
body and limits lateral protrusion71,75. The motor protein Myosin II which can 
cross-links actin filaments has been shown to be important for this process. 
While individual signaling components and pathways involved in chemotactic 
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response in T-cells are largely known or can be inferred from similar cellular 
systems, namely neutrophils and Dictyostelium, outstanding questions 
remain as to how these signaling circuits are propagated and integrated 
spatially and temporally from receptor activation at the plasma membrane to 
achieve morphological polarity and directional movement. 
 
Figure 2.2 (A) Crystal structure of SDF1α show a long and unstructured N-
terminus. (B) The two step mechanism by which chemokines (SDF1α 
shown) activate their receptor (CXCR4 shown). Figure adapted from 
Fernandez, EJ., et al., Annual Review of Pharmacology and Toxicology 
(2002) and Kofuku, Y., et al., Journal of Biological Chemistry (2009).  
A 
B 
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2.1.4 Current chemical biology tools for studying directed cell migration 
The use of fluorescent proteins allowed for some of the initial observations 
and appreciation for the highly compartmentalized nature by which proteins 
and signaling components involved in chemotaxis are orchestrated inside 
the cell. Some but not all chemokine receptors, for instance, preferentially 
localizes to the front of a migrating cell. Other molecules such ERM adaptor 
proteins are localized exclusively to the trailing uropod71.  Adding to the 
spatial complexity of these signaling events is the rapidity by which 
morphological changes occur. For example, chemokine stimulation induces 
rapid up-regulation of F-actin polymerization within seconds and ensuing 
signaling events completely transform the cell body within minutes into a 
migratory configuration80. Such spatiotemporal specificities in signal 
transduction have led to the development of chemical biology tools to perturb 
and dissect signaling downstream of chemokine receptors with high 
spatiotemporal resolution.  
In contrast to conventional methods of perturbation such as genetic 
knockdown and small molecule inhibitors, chemical biology methods, 
particularly those that allow for optical control protein functions, provide 
greater control over the timing and location of a perturbation to a signaling 
circuit. A substantial amount of efforts has gone into developing methods 
that involve the microinjection of caged inhibitory peptides or caged proteins. 
For example, a caged peptidic inhibitor of myosin light chain kinase (MLCK) 
was developed, and after microinjection into eosinophils, was shown to halt 
locomotion in a UV dependent manner81. Another strategy involves semi-
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synthesis via expressed protein ligation a caged Myosin II where a critical 
phosphor-serine residue was caged. When injected into cells, UV irradiation 
was able to restore the native phosphorylated protein82. Methods like these 
while elegant from a chemical engineering perspective are not useful to the 
extent that microinjection is necessary. There is also the issue of free 
diffusion which greatly limits the compartmentalization of the corresponding 
signaling once the microinjected effector proteins or inhibitory peptides are 
activated by light.  
Methods to control chemotactic signal transduction that make use of 
genetically encoded photosensitive proteins are less invasive to the cells. 
The focus of these technologies for the study of chemotaxis has mainly 
revolved around the Rho-GTPases due to the fundamental role they play in 
cell migration. As reviewed in chapter 1, photosensitive versions of RhoA, 
Rac1 and cdc42 have all been developed with varying degrees and ease of 
spatial control30. It is important to note that these technologies only allow for 
the control of individual signaling pathways and not the full complement of 
signaling events downstream of chemokine receptor activation. The elegant 
photoactivatable CXCR446 solves this problem but again suffers from limited 
spatial control due to lateral diffusion of the receptor in the lipid bilayer 
plasma membrane.  
We sought to develop a photoactivatable chemokine that would enable 
precise spatial and temporal control of the full complement of signaling 
downstream of  chemokine receptor activation. A photoactivatable 
chemokine would have two distinct advantages. As an extracellular ligand, it 
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could be immobilized on solid surfaces, which ensures a sustained and local 
source of activation upon decaging. A second advantage would be that cells 
would not have to be modified genetically with chimeric receptors or 
microinjected with cage reagents. 
2.2 RESULTS: 
2.2.1 Design and synthesis of a photoactivatable CXCL12/SDF1α. 
We chose to focus our efforts on developing  photoactivatable SDF1α, which 
is also known as CXCL12. SDF1α is a prototypical chemokine that has 
pleiotropic functions. SDF1α knock-out mice are embryonic lethal. Not only is 
the chemokine strongly chemotactic to leukocytes, SDF1α has been 
implicated in the migration of metastatic cancer cells. SDF1α binds to two 
GPCR chemokine receptors CXCR4 and CXCR776,83. From a structural 
stand point, SDF1α is an 8kDa protein consisting of 67 amino acids. The 
chemokine’s amino-terminal domain consisting of 8 amino acids is highly 
disordered. Mutagenesis studies identify the N-terminal lysine residue to be 
of particular important to the agonist activity of SDF1α. Specifically, 
truncation of this lysine residue (SDF1α 2-68) or its replacement with another 
basic residue (SDF1αK1R) resulted in isoforms that are orders of magnitude 
less potent than the wild type protein84. The unique reactivity of the N-
terminal lysine residue gave us a strategy to design a photoactivatable 
protein. By installing a photocleavable 4,5-Dimethoxy-2-nitrobenzyl (NVOC) 
moiety at the ε-amino position of the N-terminal lysine, we hypothesized that 
the agonist activity of SDF1α could be controlled using light (Sheme 2.1). 
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The small size of the chemokine makes it synthetically tractable via the use 
of solid phase peptide synthesis (see Materials and Methods). Using 
standard FMOC-peptide chemistry, we built the peptide chain on PEGylated 
Rink Resin support to aid solubilization and minimize chain collapse. The 
NVOC moiety was installed via the use of a commercially available FMOC-
Lys(NVOC)-OH amino acid analog. After chain extension completion, the 
NVOC-SDF1α polypeptide was cleaved, purified and refolded to produce the 
caged chemokine (see Materials and Methods for folding protocol).   
2.2.2 NVOC-SDF1α induces chemotactic response in a UV-dependent 
manner.  
To test that NVOC-SDF1α behaves as a photoactivatable chemokine, we 
performed a transwell chemotaxis assay. Primary CD8+ T-cells were 
stimulated with commercial SDF1α, NVOC-SDF1α or NVOC-SDF1α that had 
been pretreated with UV light. Whereas commercial SDF1α elicited strong 
chemotactic response, NVOC-SDF1α failed been pretreated with UV light.  
Whereas commercial SDF1α elicited strong chemotactic response, NVOC-
SDF1α failed to generate a response above background level. UV-
pretreatment to remove the NVOC-caging group completely restored the 
ability of the chemokine to induce chemotaxis. (Figure 2.3) Chemokine 
stimulation of T-cells induces strong calcium flux18. We therefore also tested 
NVOC-SDF1α in a FACS-based fluorometric calcium flux assay. Primary 
CD8+ T-cells robustly fluxed calcium in response to stimulation with 
commercially available SDF1α. 
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Scheme 2.1 Design of a photoactivatable SDF1α. The N-terminal Lysine 
residue of SDF1α is critical for its function. By installing a photo-cleavable 
NVOC group on the ε-amino group, caged SDF1α can be synthesized that 
would allow for the control of chemokine receptor activation (CXCR4) with 
UV light.  
Figure 2.3 NVOC-SDF1α is able to activate CXCR4 in a UV-dependent 
manner in a transwell assay.  
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NVOC-SDF1α, however, only induced calcium flux when UV-irradiation was 
applied prior to stimulation (Figure 2.4). The transwell chemotactic assay 
and the calcium flux experiment demonstrated that NVOC-SDF1α is a 
photoactivatable chemokine able to stimulate its cognate receptor in a UV-
dependent manner.   
Figure 2.4 NVOC-SDF1α is able to activate CXCR4 in a UV-dependent 
manner in a fluorometric calcium flux assay.  
Mouse T-cells loaded with a fluorescent calcium indicator are stimulated with 
chemotactic agents. Calcium flux is recorded using a flow cytometer. 
Increased fluorescence intensity in the FITC channel indicates an increase 
cytosolic calcium concentration. NVOC-SDF1α is unable to stimulate a 
response from primary mouse T-cells (blue line) unless irradiated with UV 
(red line.) UV irradiation completely restores the activity of the caged SDF1α 
to levels of commercial SDF1α (green line) 
2.2.3 NVOC-SDF1α can activate CXCR4 with spatiotemporal specificity. 
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As the final test of our photoactivatable chemokine, we assessed whether 
the chemokine could be used to study chemokine receptor signaling in a live 
cell videomicroscopy experiment. Chemokine stimulation of T-cells induce a 
dramatic and rapid actin-cytoskeletal response75. In order to observe this 
response, we transduced Jurkat T-cells to express Wave2 conjugated to 
GFP. Wave2 is ubiquitously expressed in cells of the hematopoetic linage 
and acts downstream of the RhoGTPase Rac1 to promote actin 
polymerization in regions of cellular activation85.  We adhered Jurkat cells 
expressing Wave2-GFP onto a glass surface coated with human fibronectin 
and NVOC-SDF1α. For these experiments, we used a Mosaic digital 
diaphragm system to deliver UV light to small regions on the surface 
beneath individual cells. Image acquisition was performed using a total 
internal reflection fluorescence (TIRF) microscope objective which allows for 
observation of signaling events occurring at and close to the plasma 
membrane. Upon photoactivation, Jurkat cells rapidly and robustly 
responded to local stimulation and directionally polarized their cell body 
(Figure 2.5A).Importantly, local irradiation of Jurkat cells on glass surfaces 
coated with fibronectin alone did not induce actin-cytoskeletal rearrangement 
and cell body polarization (Figure 2.5B). This experiment demonstrated that 
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we can use NVOC-SDF1α to control chemokine receptor activation with high 
spatiotemporal specificity.  
Figure 2.5 NVOC-SDF1α can be used in combination with a video-
microscopy platform to control chemotactic signal transduction with high 
spatiotemporal resolution. Jurkat T-cells transduced with Wave2-GFP were 
adhered to glass surfaces coated with (A) NVOC-SDF1α and fibronectin or  
(B) fibronectin alone. Circles indicate regions of focused UV irradiation. 
Purple frames indicate photoactivation. Image acquisition was done using a 
TIRF microscope objective. Yellow scale bar = 5µm and white scale bar = 
2.5 µm. Time is shown in A as MM:SS and correspond to the frames in the 
montage in B, as well.  
Having shown that NVOC-SDF1α can be used to activate chemokine 
receptor signaling with high spatial and temporal resolution in a live cell 
microscopy experiment, we wanted to apply our system to dissect the 
complex signaling circuits involved in a chemotactic response. One of the 
major signaling pathways activated downstream of chemokine receptor 
stimulation is the PI3K pathway. It is appreciated that PI3Kγ, the sole 
member of the class IB PI3K family, is involved in chemotactic signaling86,87. 
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PI3Kγ is a membrane lipid kinase consisting of a catalytic subunit p110γ and 
one of two regulatory subunits p101 and p87. Chemokine induced activation 
of PI3Kγ is dependent upon plasma membrane recruitment of the 
catalytic/regulatory subunit complex. At the plasma membrane, G proteins 
through a mechanism not yet fully understood allosterically activate the 
kinase’s phosphatidylinositol phosphorylation activity88. The plasma 
membrane recruitment of the p110γ/p101 complex is mediated via direct 
binding to the Gβγ G-protein. Accordingly, both p101and p110γ subunits 
contain Gβγ binding domains. It was not until recently, however that the 
mechanism of p110γ/p87 membrane recruitment was discovered to be 
different from that of p110γ/p101. Indeed, it was shown that upon chemokine 
receptor activation, Ras-GTP is activated and via direct binding to p110γ 
recruits the p110γ/p87 complex to the membrane89. All this characterization 
was done biochemically. The temporal and spatial aspects of these two 
distinct mechanisms of activating PI3Kγ activity remain uncharacterized. Our 
photoactivation system is uniquely suited for this purpose.  
To investigate the spatial and temporal dynamics of p101 and p87 
membrane recruitment, we transduced constructs encoding GFP fused N-
terminally to either p101 or p87 into Jurkat T-cells, and performed 
photoactivation similar to the experiment described in Figure 2.5. Upon 
photoactivation, we observed a rapid, local and sustained accumulation of 
p101 at the plasma membrane. Remarkably, this accumulation was 
restricted to within the region of UV –irradiation. GFP-p87 also accumulated 
at the region of irradiation but in a distinct spatiotemporal pattern. Upon 
photoactivation, p87 was recruited to the plasma membrane transiently. As a 
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control, we also performed photoactivation with Jurkat cells expressing GFP-
p85α, which is a regulatory subunit of class IA PI3K. As class IA PI3Ks are 
not activated downstream of chemokine receptor activation, we expected 
and indeed observed no membrane recruitment of p85 upon photoactivation 
(Figure 2.6). We also performed photoactivation in the presence of a CXCR4 
specific inhibitor, AMD3100, to confirm that the observed membrane 
recruitment of p101 and p87 was as a result of CXCR4 receptor activation 
(Figure 2.7 and Figure 2.8).  
 
 
 
 
 
Figure 2.6 Photoactivation of Jurkat T-cells specifically induces local 
clustering and membrane recruitment of the regulatory subunits of PI3Ky. 
Jurkat T-cells transduced with N-terminal GFP-tagged p101, p87 and P55 
alpha were photo activated on glass surfaces coated with NVOC-SDF1alpha 
and fibronectin. Membrane dynamics were imaged using a TIRF 
microscope. 
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Figure 2.7 Plasma membrane recruitment of p101 upon photoactivation 
requires CXCR4 activation. The line graph shows quantification of the 
clustering in the region of UV-irradiation as function of time. An increase in 
mean fluorescence intensity indicates clustering or recruitment of GFP-p101 
to the plasma membrane in the irradiated region. Jurkat cells expressing 
GFP-p101 were photo-activated on glass surface coated with NVOC-SDF1α 
in the presence of vehicle control DMSO (blue line) or the CXCR4 inhibitor 
AMD3100 (red line). Photoactivation was also performed on glass surfaces 
coated with fibronectin alone (green line) to control for UV-damage-induced 
signaling. Photoactivation is indicated by the blue vertical line. 
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Figure 2.8 Plasma membrane recruitment of p87 upon photoactivation 
requires CXCR4 activation. The line graph shows quantification of the 
clustering in the region of UV-irradiation as function of time. An increase in 
mean fluorescence intensity indicates clustering or recruitment of GFP-p87 
to the plasma membrane in the irradiated region. Jurkat cells expressing 
GFP-p87 were photo-activated on glass surface coated with NVOC-SDF1α 
in the presence of vehicle control DMSO (blue line) or the CXCR4 inhibitor 
AMD3100 (red line). Photoactivation was also performed on glass surfaces 
coated with fibronectin alone (green line) to control for UV-damage-induced 
signaling. Photoactivation is indicated by the blue vertical line. 
. 
Figure 2.9 p101 and p87 have different membrane recruitment profiles upon 
photoactivation.  
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2.3 DISCUSSION: 
We have developed a photoactivatable chemokine SDF1α. We 
demonstrated that this reagent could be used to control activation of the 
chemokine receptor CXCR4 with high spatial and temporal specificity. With 
the observations of the membrane recruitment dynamics of p101 and p87 
afforded by our photoactivation platform, we have also showed for the first 
time, the difference in the spatial and temporal aspects of signal transduction 
between the two regulatory subunits of PI3Kγ. There are outstanding 
questions to be addressed regarding the difference in p101 and p87 
membrane recruitment. From our correlation analysis (Figure 2.9), it seems 
that p101 and p87 were recruited to the membrane at approximately the 
same time suggesting that there were parallel pathways at work. It is known 
that Gβγ directly binds and recruits p101. Not much however is known 
regarding the mechanism of p87 membrane recruitment. Indeed, membrane 
bound Ras has been implicated in p87 recruitment but the intervening 
signaling pathway upstream of Ras activation and downstream of CXCR4 
stimulation is not known. As p87 recruitment was observed within seconds 
after photoactivation, the upstream signaling pathway is likely to involve 
signaling components near or at the plasma membrane. One promising 
candidate is RasGRP1 which is a prominent RAS-GEF involved lymphocyte 
signaling. In other signaling contexts, upon cellular activation, RasGRP1 is 
recruited to the plasma membrane via a diacylglycerol (DAG) dependent 
mechanism90. Upon CXCR4 activation however, it was shown that RasGRP1 
was recruited to the plasma membrane in a DAG-independent manner via 
direct binding to the Gαi G-protein91. DAG-independent recruitment of 
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RasGRP1 is therefore a fast reaction whose dynamics could support the 
rapid recruitment of p87. Assessing GFP-p87 membrane recruitment in a 
RasGRP1 shRNA knockdown background in a photoactivation experiment 
would directly address the role RasGRP1 in p87 membrane dynamics. 
Additionally, simultaneous imaging of RasGRP1 and p87 tagged with 
different fluorescent proteins would provide key correlative observations.  
Other known RasGEFs such as Grb2/SOS must also be considered.  
The broader question regarding the difference in membrane dynamics of p87 
and p101 rests on the functional implication of these two potentially parallel 
pathways in PI3Kγ activation. In mast cells and macrophages, p87 was 
shown to control degranulation and ROS-production, whereas p101 was 
shown to mediate other cellular effects89.  In neutrophil chemotaxis, it was 
revealed that PI3K signaling, upon cellular activation, was propagated by two 
functionally distinct signaling circuits. One regulated Rac-driven membrane 
protrusion while the other via unknown mechanism set up a cytoskeletal 
polarity axis within the cell92. These observations, taken together with the 
difference in the membrane recruitment dynamics of p87 and p101 that we 
observed, suggest a hypothesis where the two regulatory subunits might 
play distinct roles in regulating cytoskeletal dynamics. p101’s sustained 
membrane localization, for instance, might serve as the signal setting up the 
anterior-posterior axis which is sustained throughout the duration of a 
migratory response. By contrast, p87’s transient and burst-like membrane 
recruitment might serve as the activating signal that regulates Rac-
dependent membrane protrusion which in itself is a highly dynamic process. 
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As discussed previously in chapter 2 and the beginning of this chapter, a 
long standing interest in the field of chemotaxis focuses on the spatial and 
temporal organization of the signaling events following chemokine receptor 
activation. Our goal in developing a photoactivatable chemokine was to 
provide a tool that allows for precise perturbations and quantitative 
observations. We hope to construct a better spatiotemporal model of 
polarized signaling events that culminate in the establishment of migratory 
cell polarity and directional movement. The p101 and p87 membrane 
dynamics that we have observed are compelling examples of the kind 
quantitative and precise observations that a light-gated technology, in this 
case a photoactivatable chemokine, can provide.  
2.4 MATERIALS and METHODOLOGY:  
General methods and Reagents. Recombinant SDF1α was purchased 
from Peprotech. Human Fibronectin and AMD31000 were purchased from 
Sigma Aldrich. PCR primers and templates were purchased from Integrated 
DNA Technologies. Unless otherwise indicated, all expression plasmids 
were purchased from Addgene.  Fmoc-protected amino acids were obtained 
from Merck Millipore, and all other chemicals used in solid phase peptide 
synthesis were purchased from Sigma Aldrich. Synthesis grade organic 
solvents were from Fisher Scientific. Peptide purification and small molecule 
purification were carried out using an HPLC system (Waters) outfitted with a 
C18 reversed phase column (VYDAC.) Mass spectrometry data was 
obtained by LC-MS (Agilent Technologies) at the Memorial Sloan Kettering 
Cancer Center Mass Spectrometry Core Facility. 
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Solid Phase Peptide Synthesis of Caged SDF1α. Synthesis of the NVOC-
SDF1α was carried out using standard FMOC-solid phase peptide synthesis. 
PEGylated rink resin (NovaPEG Rink Amide Resin. Novabiochem. Catalog 
no:855047) was used for chain extension to aid with solubility and avoid 
chain collapse. SPPS reactions were carried out in a custom-made glass 
peptide synthesis vessel (Adams & Chittenden). A constant stream of 
nitrogen was used to provide gentle agitation. Amino acid coupling was 
performed using HBTU as the carboxylic acid activating agent and DIPEA as 
the organic base in DMF solvent. For each coupling reaction: 3 eq of FMOC-
AA-OH, 2.9 eq of HBTU and 3 eq of DIPEA were used. Coupling time was 
one hour at room temperature. Deprotection of FMOC was performed with 
20% Piperidine/DMF for 20 minutes. The peptide was then purified by HPLC 
using a water/acetonitrile gradient 
Folding and purification of caged SDF1. HPLC purified and lyophilized 
NVOC-SDF1α was dissolved at 0.2 mg/mL  in 1 M guanidine, 150 mM NaCl, 
3 mM EDTA, 0.3 mM reduced glutathione and 3 mM oxidized glutathione at 
pH 8.6. Folding was done at room temperature with gentle agitation for 2 
hours. Folding solution was allowed to pass through a desalting column 
(Disposable PD-10 Desalting Column. GE LifeSciences. Catalog no: 17-
0851-01) that has been buffer exchanged with PBS. Refolded NVOC-SDF1α 
was eluted with PBS and stored at 4oC.   
FACS-based fluorescent calcium flux assay. Primary T-cells were loaded 
with Flou-4AM calcium indicator (Life Technologies, catalog no: F-14201) for 
30 minutes. Cells were then washed and re-suspended in 37oC complete 
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RPMI supplemented with probenecid acid to stop dye leakage. Dye loaded 
T-cells were transferred to a FACS tube and immediately put on flow 
cytometer for data collection. During data acquisition, SDF1α dissolved in 
warm RPMI was added to the tube to a final concentration of 100ng/mL.  
Chemotaxis transwell assay. Transwell assays were carried out using a 96 
well transwell apparatus outfitted with a 5 μM filter (NeuroProbe Chemo Tx# 
101-5). T-cells were suspended in complete RPMI supplemented with 25 
mM HEPES and 10 mg/mL BSA at 1.5 million cells per mL. 45 uL aliquots of 
cell suspension were used atop each well. Chemokine was dissolved in the 
same chemotactic buffer at 4 different concentrations: 1μg/mL, 100 ng/mL, 
10 ng/mL and 1 ng/mL. Cells were allowed to migrate in tissue culture hood 
(37oC and 5% CO2) for 1 hour. The in between filter was then removed and 
cells that had migrated to the bottom wells were collected and  transferred to 
FACS tube containing 200 μL FACS cell counting buffer (PBS with 5% 
FBS,1 mM EDTA and 0.1% sodium azide) with flow cytometer reference 
beads (PeakFlow , Invitrogen Catalog no: P14825) at 20 000 beads per mL. 
The empty wells were washed once with another 200 μL FACS cell counting 
buffer. Cell counting was performed by gating on a fixed number of reference 
beads.  
Expression vector construction. Coding sequences for mouse Wave2 was 
cloned into pMSCV vector upstream of eGFP. Coding sequences of mouse 
p85α, p101 and p87 were cloned into a shuttled vector derived from pTOPO 
(Intvitrogen) downstream of GFP (NT-GFP-TOPO). Fragments encoding the 
fusion protein were then cut out and ligated into pMSCV.  
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Cell Culture and Retroviral Transduction. Jurkat E 6.1 T-cells (American 
Type Culture Collection) were maintained in complete RPMI supplemented 
with 10% fetal bovine serum (FBS) and antibiotics. Transduction was carried 
using an amphotrophic  retroviral system with pMSCV expression plasmids 
and pCMV-Gag-Pol packaging plasmid. Pheonix A cells at about 90% 
confluency were transfected with the aforementioned retroviral expression 
and packaging plasmids by calcium phosphate method. Viral supernatants 
were collected after 48 hr at 370C and added to 1 million exponentially 
dividing Jurkat cells (which were subcultured two days prior at 200 000 cells 
per mL) in a 6-well tissue culture plates. Mixtures were subsequently 
centrifuged at 1000 g in the presence of polybrene (4 μg/mL) at 350C for 2 hr 
and allowed to incubate overnight at 370C.  Cells were then expanded in 
fresh medium. 
Photoactivation and TIRF video microscopy experiment. Glass surfaces 
for photoactivation were prepared from eight-well chamber slides (Nunc). 
Chamber slides were washed in Hellmanex III solution (Hellma Analytics, 
Catalog no: 9-307-010-507), rinsed thoroughly and stored in double distilled 
water. The day before imaging, 150 μl mixture of fibronectin (20 μg/mL) and 
chemokine (100 ng/mL) was added to each well and incubated overnight at 
40C. Just before imaging, the coated glass slides were allowed to warm up 
to room temperature and washed three times with PBS. Jurkat cells were 
allowed to adhere to coated chamber slides for 10 mins before data 
collection in cRPMI. For pharmacological treatment, inhibitor (AMD3100 at 5 
μM) was added after imaging acquisition had been done on at least 3 cells. 
Live imaging experiments were carried out using an inverted fluorescence 
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video microscope fitted with a 150X objective with a numerical aperture of 
1.45 (Olympus).  Laser at 488 nm (Melles Griot) was used for 
epifluorescence imaging of GFP. A Mosaic digital diaphragm apparatus 
(Photonic Instruments) attached to a mercury (HBO) lamp (Olympus) was 
used for photoactivation. Time-lapse recordings were made with Slidebook 
software (Intelligent Imaging Innovations). Images were acquired every 3 
seconds. Cells were activated with a UV exposure of 3 seconds.  
P101 and P87 recruitment quantification. GFP-p101 and GFP-p87 
membrane recruitment were quantified by determining the mean 
fluorescence intensity inside of the irradiated regions, after background 
correction, as a function of time.  Image analysis was performed using 
Slidebook, Microsoft Excel, and GraphPad Prism. 
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CHAPTER 3: A generalizable platform for the photoactivation of cell surface 
receptors 
3.1 INTRODUCTION:  
3.1.1 The biological significance of cell polarity.  
Cell polarity is the asymmetrical organization of cellular structures and 
components within the cell. It is a fundamental process that allows cells 
across the phyla to effectively carry out their biological purposes. Cell 
polarity is most evident in cells that have specialized functions. Neurons, for 
example, exhibit dramatic polarization of the cell body. During development, 
neural progenitors transform from isotropic spheres into a complex and 
polarized architecture containing several shorter dendrites at one end and a 
long axon at the other93. The extension of the axons is driven by highly 
polarized cellular structures called growth cones. The growth cone functions 
by sensing environmental cues in the form of soluble ligands and translates 
those signals into cytoskeletal dynamics to support directional growth of the 
axon94. The compartmentalization of the neuronal cell body into molecularly 
and functionally distinct segments, in other words its polarity, is critical to a 
neuron’s development and the functionality of neuronal networks. Similar to 
the concept of growth cones driving axon extension, during vasculogenesis, 
certain endothelial cells lining blood vessels, via unknown mechanism, 
assume the role of guiding “tip” cells, which upon detecting extracellular 
angiogenic cues polarize their cell body and migrate outward95. The 
polarization of blood vessel endothelial cells into tip cells is the critical first 
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step in the “sprouting” of new blood vessels from existing ones in response 
to extracellular signals.  
Migratory cells represent another dramatic example of cell polarity. As has 
been discussed in greater detail in chapter 2, the breaking of symmetry and 
polarization of the cell body into a migratory form is the critical first step to 
ensure productive directional migration of leukocytes in response to 
extracellular stimuli. Another form of cell polarity that is critical to the function 
of a T-cell occurs during cell-to-cell contact between an antigen specific T-
cell and an antigen-presenting target cell. T-cells function in part by making 
direct contact with target cells after which the T-cells would, depending on 
context, directionally secret of cytotoxic factors or regulatory cytokines and 
exert cell-mediated immunity. Stimulation of the TCR by a target cell induces 
dramatic reorganization of the T-cell’s body whereby a special structure is 
formed at the contact interface known as the immunological synapse96. It is 
towards the immunological synapse that an activated T-cell polarizes critical 
organelles and structures such as the microtubule organizing center (MTOC) 
and secretory machinery. Such cellular polarization facilitates directional 
secretion which is central to the function of a T-cell97. It is worth noting that 
very similar forms of cell polarity exist in other cell-cell contact contexts such 
as virological synapses, which form between virally infected T-cells, and NK 
cells synapses, which form between NK cells and their target cells.  
Given that cell polarity is crucial for many of the complex biological 
processes we associate with eukaryotic cells, it is unsurprising that cell 
polarity and the dys-regulation of it significantly to disease conditions. The 
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pathology of arthritic joints, for example, is characterized by the recruitment 
and infiltration of inflammatory leukocytes to the affected joints98 . Therapies 
aimed at reducing the migration of inflammatory leukocytes to the arthritic 
joints are currently in the clinical trials. In tumor biology, the loss of epithelial 
cell polarity initiates the epithelial-mesenchymal transitions (EMTs) that turn 
healthy polarized epithelial cells into mesenchymal cells that are resistant to 
apoptosis and exhibit increased migratory capabilities99. The dys-regulation 
of epithelial cell polarity ultimately leads to invasive oncogenic growth and 
metastasis 99,100.  
3.1.2 The acquisition and maintenance of cell polarity are driven by cell 
surface receptors and their cognate extracellular ligands. 
The segregation of cellular and signaling components into spatially distinct 
regions in the cell during polarized signal transduction is initiated at the 
plasma membrane. Cell surface receptors, activated by the binding of 
extracellular ligands, trigger cascades of signaling events that propagate 
down throughout the cell cytoplasm. The integration of these signaling 
events in space and time sets up a polarity axis inside the cell and facilitates 
subsequent cellular processes. In the case of the neuronal growth cone, cell 
surface receptors detect molecular guidance cues in the form of soluble 
secreted proteins. Upon activation, these cell surface receptors initiate 
signaling cascades that culminate in the reorganization of the cytoskeleton to 
move or turn the growth cone in the direction from which the extracellular 
cues originate94. In the case of chemotaxis in lymphocytes, a similar 
polarized signal transduction program is observed. Chemoattractants, upon 
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binding to chemokine receptors, trigger signal transduction programs to 
polarize the cell body and propel the cell towards the source of the 
chemoattractants75. Similar processes of polarized signal transduction from 
cell surface receptors underlie other forms of cell polarity such as tip cells’ 
polarization during vasculogenesis and the formation of the immunological 
synapse upon TCR activation.  
While the individual proteins and pathways that get activated to initiate and 
maintain cell polarity in different contexts have mostly been identified and 
characterized, much less is understood regarding how these circuits are 
integrated temporally and spatially throughout the cell. Traditional 
experimental tools such as genetic knockdown and small molecule inhibitors 
are great at identifying key players in polarized signal transduction. Such 
techniques however lack the spatial and temporal control to provide 
quantitative measurements about polarized signaling dynamics. High 
resolution imaging techniques coupled with the use of fluorescent proteins 
and antibody staining, while useful in providing snapshots of the spatial 
organization of circuits downstream of cell surface receptor activation during 
polarized signaling, cannot be used to perturb and establish cause and 
effects relationships between signaling events. Deciphering the complex 
molecular choreography involved in cell surface receptor polarized signaling 
requires tools that combine the monitoring and perturbation of signaling 
pathways with high spatiotemporal resolution.  
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3.1.3 Photo-caged extracellular ligands are effective tools to perturb 
polarized signaling from cell surface receptors with high spatiotemporal 
resolution.  
In recent years, a number of optogenetic systems have been engineered for 
the controlled activation of cell surface receptors. As summarized in chapter 
1, light sensitive rhodopsin-GPCR chimeras (optoXRs) have emerged as 
useful tools in the studies of neuronal transmission and cellular 
chemotaxis45,46.  In addition, photosensitive proteins derived from plants 
have been used to enable light-controlled stimulation of cell surface 
receptors and/or their downstream signaling components. Although these 
methods provide exquisite control over where and when signaling molecules 
are activated, restraining the rapid diffusion of these molecules away from 
the illuminated region after stimulation has proven to be a formidable 
technical challenge.  This has limited the applicability of optogenetics in 
studies that require both sustained and subcellular stimulation.  
As previously discussed, photo-caged ligands immobilized on solid surfaces 
provide both spatial and temporal control of the activating signal. Chapter 2 
described one such photocaged ligand. The caged ligand developed there 
was the chemokine SDF1α. While the critical role of the chemokine’s N-
terminal lysine residue and the relatively small size of the protein lent 
themselves easily to a caging strategy and straightforward chemical 
synthesis, the majority of protein ligands present major photocaging design 
hurdles. For example, protein ligands can be large in size which limits 
synthetic access. Furthermore, ligands can have complicated mechanisms 
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of activating their receptors where the agonist activity is not localized to any 
particular residues but is rather controlled by structural domains or motifs. In 
such cases, effective photocaging strategies would either be too 
cumbersome or technically unfeasible. It would be of great interest therefore 
if there were a universal ligand platform that allows for the activation of 
multiple cell surface receptors via the use of one single caged ligand. Such a 
system would sidestep the challenge of having to design and engineer an 
individual photocaged ligand for every receptor. 
3.1.4 The design of a universal caged ligand platform relies on the 
modularity of receptor proteins.  
Many cell surface receptors, including receptor tyrosine kinases (RTKs) and 
cytokine receptors, are type I transmembrane proteins that function via 
ligand-induced dimerization. In this regime, the act of ligand binding brings 
together two receptor chains such that their cytoplasmic tails, which either 
contain tyrosine kinase domains or interact with non-receptor tyrosine 
kinases, become close enough to promote trans-autophosphorylation and 
downstream signaling.  The extracellular domains of the receptor typically 
mediate ligand binding, while the intracellular tails control signal 
transduction. This architectural modularity has allowed for the design of 
functional chimeric receptors that contain the cytoplasmic tail of one receptor 
fused to the extracellular domain of another.  In principle a ligand for one 
receptor could be used to activate signaling associated with another receptor 
via the use of chimeras. Hence, if one could develop an effective caged 
ligand for a “parent” receptor-ligand pair, it could, in principle, be used to 
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elicit signaling from a wide range of chimeric receptors containing the 
extracellular domain of the parent receptor and the intracellular signal 
transduction domains of other receptors of interest.  
Erythropoietin receptor (EpoR) and its ligands are uniquely suited as the 
parent receptor-ligand pair for the development of the universal caged 
ligand-chimeric receptor platform. EpoR is a well characterized prototypical 
type 1 transmembrane cytokine receptor. EpoR and its cognate ligand Epo 
are key regulators of erythropoiesis – the differentiation of red blood cells 
from hematopoietic progenitors. The binding of the166 AA Epo protein, to 
EpoR, which exists as a preformed dimer, induces conformation changes 
that lead to receptor activation101,102. Importantly, EpoR  has been 
successfully used to create functional chimeric receptors containing the 
extracellular domain of EpoR fused to the transmembrane and intracellular 
domains of other receptors103,104. EpoR-chimeras are therefore likely to be 
functional receptors. From the photo-caged ligand perspective, the large size 
of the Epo protein renders the design of a caged ligand difficult. Interestingly 
however, a small 20 amino acid long peptide called EMP1 was discovered to 
be a potent activator of EpoR with nanomolar affinity105,106. Furthermore, a 
structural study of EMP1 has localized the agonist activity of the ligand to a 
tyrosine residue near the N-terminus (tyrosine 4)105. It follows then that a 
caged ligand for EpoR could be synthesized by installing a UV-cleavable 
group onto EMP1 Tyr4.  
We hypothesized that the use of chimeric receptors containing the 
extracellular domain of EPOR and the intracellular domains of receptors of 
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interest, in combination with a photo-caged EMP1 ligand, would constitute a 
universal platform to control cell surface receptor activation via light-induced 
receptor dimerization. We envisioned the photo-caged EMP1 ligand platform 
to be a tool that allows for sustained, local stimulation of cell surface 
receptors. By adhering cells expressing chimeric receptors of interest on top 
of glass surface pre-coated with caged EMP1 ligand, focused light pulses 
could be used to locally de-cage and deliver an activating signal to the cell. 
As the decaged ligands would remain bound to the glass surface outside of 
the cell, a sustained and spatially constrained activating signal could be 
achieved (Figure 3.1)   
 
The rest of this chapter will discuss the synthesis of a caged analog of the 
EMP1 ligand. It also details experiments validating the utility of this 
photosensitive ligand to activate a range of cell surface receptors in a light 
dependent manner. Finally, it describes efforts to demonstrate that this 
universal platform can be used in live cell videomicroscopy experiments to 
activate cell surface receptors in a spatiotemporally precise manner. The 
strategy to synthesize a caged EMP1 ligand focuses on Tyrosine 4. 
Mutagenesis studies have shown that replacement of this amino acid with 
non-polar amino acids such as Phenylalanine or Alanine reduced the agonist 
activity of the ligand by 2 orders of magnitude105. We reasoned that by 
installing a UV-cleavable NVOC group on the side chain of Tyr4, the agonist 
activity of EMP1 would affectively be photo-caged. . The strategy to 
synthesize a caged EMP1 ligand focuses on Tyrosine 4. 
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Figure 3.1 A generalizable platform for the UV dependent activation of cell 
surface receptors. (A) EMP1 is photocaged on Tyr4 with a UV-sensitive 
caging group and contains a C-terminal biotin tag.  It cannot dimerize EpoR 
until UV irradiation removes the caging moiety (in red). (B) Schematic of a 
photoactivation videomicroscopy experiment.  Caged EMP1 ligand is 
immobilized via a streptavidin-biotin linkage on a glass coverslip.  After cells 
are attached to the glass, focused UV light is used to decage the surface 
beneath an individual cell.  Subsequent receptor activation and signal 
transduction can be observed in real time using fluorescent signaling probes. 
.3.2 RESULTS:  
3.2.1 Synthesis of a caged EMP1 ligand.  
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The strategy to synthesize a caged EMP1 ligand focuses on Tyrosine 4. 
Mutagenesis studies have shown that replacement of this amino acid with 
non-polar amino acids such as Phenylalanine or Alanine reduced the agonist 
activity of the ligand by 2 orders of magnitude105. We reasoned that by 
installing a UV-cleavable NVOC group on the side chain of Tyr4, the agonist 
activity of EMP1 would affectively be photo-caged. We hypothesized that 
bulky NVOC group would interfere with critical interactions between the 
ligand and EPOR otherwise facilitated by Tyr4.  The synthesis of the photo-
caged EMP1 hereafter referred to as NVOC-EMP1, was carried out via 
FMOC-solid phase peptide synthesis. The full sequence of NVOC-EMP1 
includes a 23 amino acid polypeptide of the following composition:  
GGTY(NVOC) SCHF GPLT WVCK PQGG SSK(Biotin). We extended the 
original EMP1 peptide by adding three additional amino acids SSK at the C-
terminus to facilitate the installation of a biotin molecule. A biotinylated EMP1 
is important for glass surface immobilization via the use of streptavidin. The 
synthesis of EMP1 is outline in Scheme 3.2. The complete secondary 
structure of EMP1 ligand features a disulfide bond formed between the two 
cysteine residues. Since there are only two cysteine residues present in the 
peptide, disulfide bond formation was straightforward. After HPLC 
purification and lyophilization, the peptide was dissolved in 10% 
DMSO/phosphate buffered saline (PBS) and exposed to air overnight to 
induce disulfide bond formation. To confirm that upon UV irradiation the 
NVOC undergoes a clean photolysis from the EMP1 peptide, we subjected 
the molecule to irradiation using a hand-held UV lamp and analyzed the 
product by HPLC and mass spectrometry. As expected, UV-irradiation of this 
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peptide removed the NVOC moiety, yielding the unmodified EMP1 (Figure 
3.3). 
Figure 3.2 Synthesis of NVOC-EMP1. i) Rink resin, Fmoc-AA-OH, HBTU, 
DIPEA in DMF; FMOC-Tyr(NVOC)-OH, HBTU, DIPEA in DMF; Fmoc-AA-
OH, HBTU, DIPEA in DMF; 82.5% TFA, 5% water, 5% phenol, 5% 
thioanisole, 2.5% 1,2-ethanedithiol. Rink resin, Fmoc-AA-OH, HBTU, DIPEA 
in DMF; FMOC-Tyr(NVOC)-OH, HBTU, DIPEA in DMF; Fmoc-AA-OH, 
HBTU, DIPEA in DMF; 82.5% TFA, 5% water, 5% phenol, 5% thioanisole, 
2.5% 1,2-ethanedithiol. Rink resin, Fmoc-AA-OH, HBTU, DIPEA in DMF;  
FMOC-Tyr(NVOC)-OH, HBTU, DIPEA in DMF;  Fmoc-AA-OH, HBTU, 
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Figure 3.3 (A) Reversed phase elution profiles of NVOC-EMP1 (Black) and 
NVOC-EMP1 irradiated with a handheld UV lamp for 15 minutes (Red). UV 
irradiation removes the NVOC moiety from the phenolic oxygen of Tyr4 and 
shifts the elution profile of the peptide. (B) ESI mass spectrometry analysis 
of purified absorption peak (i). The predicted molecular weight of NVOC-
EMP1 (C125H180N32O37S3) is 2817.25. Found [M+H]3+: 940. (C) ESI mass 
spectrometry analysis of purified absorption peak (ii).  
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3.2.2 NVOC-EMP1 is a photoactivatable ligand for EpoR 
Before using NVOC-EMP1 as a ligand to activate chimeric receptors, we 
wanted to assess the capacity of NVOC-EMP1 to function as a caged ligand 
for its cognate receptor EpoR. We performed a bioassay using  the TF1 cell 
line. TF1 cells were established from a patient with erythroleukemia. These 
cells express EpoR at a high level and stimulation with Epo induces their 
differentiation along the erythroid lineage107. Treatment of TF1 cells with Epo 
induces robust phosphorylation of the transcription factor Stat5a (Figure 3.4). 
When used to stimulated TF1 cells in solution, NVOC-EMP1 failed to induce 
this response, suggesting that the caging group disrupts productive EpoR 
binding. After UV irradiation, however, the peptide elicited strong Stat5a 
phosphorylation (Figure 3.5). Hence, NVOC modification of EMP1 on Tyr4 
effectively photocages the activity of this molecule. Treatment of TF1 cells 
with Epo induces robust phosphorylation of the transcription factor Stat5a 
(Figure 3.4). When used to stimulated TF1 cells in solution, NVOC-EMP1 
failed to induce this response, suggesting that the caging group disrupts 
productive EpoR binding. After UV irradiation, however, the peptide elicited 
strong Stat5a phosphorylation (Figure 3.5). Hence, NVOC modification of 
EMP1 on Tyr4 effectively photocages the activity of this molecule. Treatment 
of TF1 cells with Epo induces robust phosphorylation of the transcription 
factor Stat5a. 
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Figure 3.4 EPO stimulation of TF1 cells induces phosphorylation of Stat5a.  
Serum and cytokine starved TF1 cells were stimulated with EPO at indicated 
concentrations for 10 minutes. Cells were immediately lysed and phosphor-
Stat5a levels were assessed by immunoblot.  Actin served as a loading 
control 
Figure 3.5 TF1 cells were treated with the indicated concentrations of 
NVOC-EMP1 that had either been irradiated with UV light or left untreated. 
EpoR signaling was assessed by immunoblot for phosphorylated Stat5a. 
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3.2.3 NVOC-EMP1 can act as a photoactivatable ligand for multiple 
receptors.  
Having proved that NVOC-EMP1 is an effective ligand to control the 
activation of EpoR in a UV-dependent manner, the next step was to prove 
that we could use NVOC-EMP1 to access other signaling systems using 
EpoR chimeras.  Our initial efforts focused on two receptor tyrosine kinases, 
Epidermal Growth Factor Receptor (EGFR) and Tropomyosin receptor 
kinase A (TrkA).  EGFR regulates growth and homeostasis in multiple 
epithelial cell types and is often dysregulated in cancer108.  Upon binding to 
its cognate ligand EGF, EGFR undergoes a series of conformation changes 
resulting in the phosphorylation of tyrosine residues in the receptor’s 
cytoplasmic domain which can be detected biochemically (Figure 3.6). Due 
to the robustness of the tyrosine phosphorylation events as readouts for 
receptor activation upon ligand binding, we chose EGFR as the first proof of 
principle test receptor for the NVOC-EMP1-EpoR chimeric platform.   
Figure 3.6 NIH3T3 cells were transfected to express full length EGFR and 
stimulated with EGF at the indicated concentrations.  
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To demonstrate that NVOC-EMP1 can drive EGFR dependent signals, we 
prepared chimeric constructs containing the extracellular domain of EpoR 
and the cytoplasmic domains of EGFR.  NIH-3T3 cells expressing the EpoR-
EGFR chimera were unresponsive when treated with NVOC-EMP1, as 
evidenced by the absence of ligand-induced receptor phosphorylation 
(Figure 3.7).  Treatment of these cells with the UV-irradiated peptide, 
however, elicited robust signaling, validating both the functionality of the 
EpoR-EGFR construct and the efficacy of NVOC-EMP1 as a caged ligand. 
We next looked at TrkA. TrkA is a receptor tyrosine kinase that is highly 
expressed in the nervous system. Upon binding to its cognate ligand, nerve 
growth factor (NGF), TrkA undergoes dimerization followed by 
autophosphorylation and a signaling cascade109. NGF was the first identified 
neurotrophin and has a wide range of functions in neuronal development. 
TrkA-NGF signaling for example regulates neuron survival. In vitro treatment 
of dorsal root ganglion (DRG) with NGF strongly promotes nerve fiber 
elongation and sprouting. In the context of neuronal cell polarity, upon 
detecting NGF in the extracellular environment, TrkA initiates polarized 
signaling cascades that culminate in the turning of axon growth cones 
towards the source of NGF110. Since the purpose of the development of the 
NVOC-EMP1 is to aid in the study of receptor surface receptors that regulate 
cell polarity, TrkA was an interesting receptor.  
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Figure 3.7 NIH-3T3 cells expressing EpoR-EGFR were treated with the 
indicated concentrations of NVOC-EMP1 that had either been irradiated with 
UV light or left untreated. EGFR signaling was assessed by immunoblot for 
Tyr 1068 phosphorylation.  
To demonstrate that NVOC-EMP1 can be used to activate TrkA dependent 
signaling in a UV dependent manner, we created chimeric constructs 
containing the extracellular domain of EpoR and the cytoplasmic domains of 
TrkATrkA activates the mitogen-activated protein kinases (MAPK) 
pathway109. Indeed, when expressed in NIH3T3 cells, full length TrKA 
receptors were able to rapidly and robustly induce the phosphorylation of 
Erk1/2 (Figure 3.8). We therefore used the phosphorylation states of Erk1/2 
as the biochemical readouts for TrkA dependent signaling. By assessing 
Erk1/2 phosphorylation, we observed that only treatment with UV-irradiated 
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NVOC-EMP1 induced TrkA dependent signaling in cells expressing EpoR-
TrKA (Figure 3.9).  
Figure 3.8 NIH3T3 cells were transfected to express full-length TrKA and 
stimulated with NGF for the indicated times. Activation of TrkA dependent 
signaling was monitored by the phosphorylation of status of Erk1/2.  
Figure 3.9 NIH-3T3 cells expressing EpoR-TrkA were treated with the 
indicated concentrations of NVOC-EMP1. TrkA signaling was assessed by 
immunoblot for phosphorylation of Erk1/2 
68 
 
Using Erk1/2 phosphorylation as the readout for TrKA dependent signaling 
provided an experimentally robust and rapid way to assess the functionality 
of the EpoRTrkA system. The MAPK kinases pathway is however only one 
of the many signaling pathways that gets activated downstream of NGF 
binding.  We wanted to find another assay that allows for a broader 
assessment of TrKA signaling.  The pheochromocytoma cell line PC12, 
which expresses TrkA, responds to NGF stimulation by adhering to the 
extracellular matrix and growing extended neurites111. We therefore used 
this PC12 NGF dependent cellular differentiation phenotype as a way to 
further examine the capacity of NVOC-EMP1 to elicit TrkA signaling in a light 
inducible manner. Specifically, PC12 cells expressing EpoR-TrkA, upon 
treatment with NVOC-EMP1, should in a UV-dependent manner undergo 
TrkA-dependent differentiation. As a control, we needed to first determine 
that no EpoR-dependent differentiation occurs in these cells. Indeed, Epo 
dependent neurite outgrowth was not observed in untransfected cells (Figure 
3.10A). We next tested the ability of NVOC-EMP1 to activate TrkA 
dependent signaling. We incubated EpoR-TrkA expressing PC12 cells with 
NVOC-EMP1 that was either untreated or irradiated with UV light. Only 
irradiated NVOC-EMP1 induced robust PC12 differentiation (Figure 3.10B), 
indicating that this ligand is capable of inducing the full complement of TrkA 
dependent signaling responses in a UV-dependent manner. 
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Figure 3.10 EpoR-TrkA signaling induces neurite outgrowth in PC12 cells. 
(A) PC12 cells were allowed to differentiate on collagen coated tissue culture 
plates in response to stimulation by EPO (10 ng/mL), NGF (20 ng/mL) or 
medium at 370C for three days. Representative end-point phase contrast 
images of PC12 cells morphology are shown. Scale bars = 20 μm (B) PC12 
cells expressing EpoR-TrkA were stimulated on collagen coated tissue 
culture plates for three days with medium, EPO (10ng/mL), untreated NVOC-
EMP1 or UV-irradiated NVOC-EMP1 at the indicated concentrations. 
Representative end-point phase contrast images of each condition are 
shown. Scale bars = 100 μm. 
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The two receptors, EGFR and TrkA, tested above both belong to the 
receptor tyrosine kinase superfamily. To further demonstrate the universality 
of the NVOC-EMP1-EpoR chimeric platform, we asked if our approach could 
be applied to a receptor outside the RTK family. Toll-like receptor 4 (TLR4) is 
a single pass transmembrane receptor that gets activated via ligand-induced 
dimerization.  Unlike RTKs however, TLR4 is non catalytic. The receptor 
plays a crucial role in the innate immune system by mediating cellular 
responses to its cognate ligand lipopolysaccharide (LPS).  That TLR4 
engages a lipid ligand is also of interest to us. Designing a caged ligand for 
LPS would be very difficult due to the chemical complexity of the glycolipid 
composition. LPS binding of TLR4 induces the transduction of inflammatory 
signals, some of which are mediated by the adaptor protein MyD88 and the 
transcription factor NF-κB112. The activation of this pathway can be 
monitored biochemically by the degradation of IκBα, an inhibitory scaffold 
that sequesters NF-κB in the cytoplasm (Figure 3.11)  Using the degradation 
of IκBα as a biochemical proxy for TLR4-dependent signaling, we next set 
out to demonstrate that NVOC-EMP1 could be used to drive TLR4 signaling 
in a UV-dependent manner. We prepared an EpoR-TLR4 chimera and 
transduced the construct into RAW 264.7 macrophages.  Treatment of these 
cells with UV-irradiated NVOC-EMP1, but not the but not the unirradiated 
peptide, elicited robust IκBα degradation (Figure 3.12), validating the 
potential of NVOC-EMP1 to drive UV-dependent signals through EpoR-
TLR4. 
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Figure 3.11 TLR4-dependent signaling in RAW 264.7 macrophage cell line. 
RAW 264.7 macrophages were treated with LPS (1μg/mL) for the indicated 
times, and IκBα assessed by immunoblot.  Actin served as a loading control. 
 
Figure 3.12 RAW 264.7 cells expressing EpoR-TLR4 were treated with the 
indicated concentrations of NVOC-EMP1. 
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3.2.4  NVOC-EMP1 can activate receptors in spatiotemporally specific 
manner.  
As outlined in the introduction of this chapter and in scheme 3.1, the goal for 
developing the NVOC-EMP1-EpoR chimeric system was to implement a 
videomicroscopy platform, where cell surface receptors could be activated in 
a spatiotemporally specific manner and the ensuing signaling dynamics 
could be imaged and quantitatively measured.  We therefore set out to 
determine this very possibility. 
Among the three different receptors that we had validated biochemically, 
TLR4 signaling could be robustly  monitored in real time by fluorescently 
labeling the P65 subunit of NF-κB113. LPS stimulation of TLR4 results in the 
nuclear translocation of this transcription factor.  Accordingly, we transduced 
RAW 264.7 macrophages with GFP- and RFP-tagged forms of P65.  
Treatment of these cells with LPS induced the translocation of P65-GFP and 
P65-RFP into the nucleus within 20 minutes, indicative of strong NF-κB 
signaling (Figure 3.13A. and data not shown.)  We also observed this 
response after applying Epo to RAW 264.7 cells that expressed EpoR-TLR4 
(Figure 3.13B.)  Importantly, Epo failed to induce NF-κB translocation in cells 
lacking the chimeric receptor, confirming the specificity of our approach 
(Figure 3.13C.)   
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Figure 3.13 EPO can induce TLR4 dependent signaling (p65 nuclear 
localization) through chimeric receptor EPOR-TLR4. Time-lapse montages 
show (A) raw cells expressing p65-GFP and stimulated with LPS (1 μg/mL), 
(B) raw cells expressing EPOR-TLR4-GFP and p65-RFP and stimulated with 
EPO and (C) raw cells expressing p65-GFP and stimulated with EPO. All 
stimuli were added at the start of the experiment (Time 00:00). p65 nuclear 
localization is indicated by white arrows. Scale bars = 10 μm. Time in 
HH:MM is indicated in the top left corner of each image. 
To photoinduce TLR4 signaling during a live imaging experiment, we 
adhered RAW 264.7 cells expressing EpoR-TLR4-GFP and P65-RFP to 
glass surfaces coated with NVOC-EMP1, which we immobilized using an 
established streptavidin-biotin approach11. Then, we used a UV light source 
coupled to an optical digital diaphragm to irradiate the surface beneath a 
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group of cells.  A brief (5 seconds) pulse of UV was sufficient to induce P65 
translocation into the nucleus (Figure 3.14A), similar to what we had 
observed in cells treated with soluble Epo.  Importantly, UV irradiation had 
no effect on P65 localization in the absence of immobilized NVOC-EMP1 
(Figure 3.14B), indicating that the translocation response we observed 
resulted from bona fide TLR4 signaling rather than phototoxicity.  
Figure 3.14  A representative time-lapse montage showing translocation of 
P65-RFP to the nucleus after a 5 second UV pulse, denoted by yellow text. 
White arrows indicate nuclear localization of P65.   
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The p65 photoactivation experiment demonstrated that the NVOC-EMP1 
platform could photo-induce TLR4 dependent signaling under the 
microscope. It also highlighted the precise temporal control of TLR4 
signaling with the use of UV. What the low-magnification photo-activation 
experiment did not demonstrate, however, was the extent to which 
subcellular spatial resolution could be achieved with the NVOC-EMP1 
ligand. To highlight the spatial resolution of the platform, we decided to 
photo-activate EpoR-TLR4 expressing macrophages at a higher 
magnification where subcellular regions of cells could be selectively 
irradiated with UV. For these experiments, we used an optical digital 
diaphragm system to deliver UV light to small regions of the surface beneath 
individual cells adhered to surface pre-coated with caged ligand. The spatial 
resolution at which the NVOC-EMP1 platform can stimulate cell surface 
receptor activation would then depend on the ability of the optical system to 
decage the immobilized ligand in a spatially precise manner. We therefore 
needed to first test the system’s ability to focus UV light and induce 
photolysis in a spatially defined way.  
 
5- carboxymethoxy-2-nitrobenzyl (CMNB) carboxyfluorescein is a photo-
caged green fluorophore. In its photo-caged form, CMNB carboxyfluorescein 
fluoresces weakly. Upon UV irradiation which induces photolysis of the 
CMNB caging group, the decaged carboxyfluorescein recovers its 
fluorescence. CMNB is chemically similar to NVOC and shares the same 
mechanism of UV-induced photolysis114. Furthermore, efficient and spatially 
precise de-caging of CMNB carboxyfluorescein would result in a sharp  
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increase in green fluorescence that is spatially constrained in the region 
targeted for irradiation. For these reasons, we used CMNB 
carboxyfluorescein as proxy for NVOC-EMP1 to test the spatial resolution of 
our irradiation system. The experiment involved coating glass with CMNB 
carboxyfluorescein and using the  digital diaphragm to deliver UV-light onto 
regions of various sizes. We found that the system can achieve clean and 
uniform decaging of circular areas less than 5 μm in diameter (Fig. 3.15). 
 
Finally, having confirmed the spatial precision of our irradiation apparatus, 
we set out to photo-activate EpoR-TLR4. To assess TLR4 activation, we 
relied on the receptor’s known activation-induced oligomerization. Previous 
studies have shown that TLR4 undergoes rapid oligomerization within 
minutes of ligand binding, forming clusters on the plasma membrane that 
persist for up to 50 minutes115,116. Since the EpoRTLR4 expression construct 
contains a fluorescent eGFP protein at the C-terminus, clustering at the 
membrane as a result of TLR4 dependent signaling could be easily imaged 
and quantified. Accordingly, we adhered RAW cells expressing EpoRTLR4 
onto a glass surface pre-coated with NVOC-EMP1. We used total internal 
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reflection fluorescence (TIRF) imaging  to record signaling events at the 
plasma membrane.  
Figure 3.15. Constrained decaging by the Mosaic digital diaphragm. (A) 
Reaction diagram showing UV decaging of 5- carboxymethoxy-2-nitrobenzyl 
(CMNB) carboxyfluorescein. (B) Glass surfaces coated with immobilized 
CMNB carboxyfluorescein were subjected to focused UV irradiation.  
Representative images taken before and after decaging are shown, with the 
region of UV irradiation indicated by the circles to the left. Scale bars = 10 
μm. 
Using the digital diaphragm system, we irradiated a subcellular region on a 
cell. Irradiation in this manner induced rapid clustering of EpoR-TLR4-GFP 
(Fig. 3.16).  Importantly, cluster formation was significantly more pronounced 
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within the irradiated region, demonstrating that NVOC-EMP1 can be used in 
conjunction with focused UV light to elicit signaling responses in the plasma 
membrane with spatial precision. As a control for UV-toxicity, we irradiated 
EpoT-TLR4 expressing cells on glass surface with no caged ligand. This 
response was not observed in the absence of NVOC-EMP1 which indicates 
that it resulted specifically from ligand engagement by EpoR-TLR4-GFP (Fig. 
3.17).   
 
 
 
 
 
 
 
 
 
 
Figure 3.16. Constrained NVOC-EMP1 photoactivation can be used to elicit 
localized signaling responses. RAW 264.7 cells expressing EpoR-TLR4-GFP 
were imaged and UV-irradiated on glass surfaces coated with NVOC-EMP1. 
epresentative time-lapse montage showing receptor cluster formation after UV 
activation  
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Figure 3.17. UV alone does not induce clustering of EpoR-TLR4. RAW 
264.7 cells expressing EpoR-TLR4-GFP were imaged and UV-irradiated on 
glass surfaces without NVOC-EMP1. (A) Time-lapse montage of a 
representative experiment, with the region of irradiation (3 s pulse) denoted 
by the green circle and the time of irradiation by yellow text. Time in 
HH:MM:SS is indicated in the top left corner of each image. Scale bars = 5 
μm. (B) Quantification of experiment shown in (A). Cluster formation was 
quantified by calculating the normalized mean fluorescence intensity inside 
and outside the irradiated region. UV irradiation is indicated by the purple 
line. Error bars denote s.e.m.  Data are representative of two independent 
experiments (n≥10 cells per condition). 
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3.3 DISCUSSION 
In summary, we have established NVOC-EMP1 as a generalizable platform 
for the photoactivation of a wide range of receptor signaling pathways. We 
have also validated the potential of this molecule to elicit pathway specific 
signaling responses in real time during videomicroscopy experiments with 
both spatial and temporal specificity.  The application of NVOC-EMP1 
together with EpoR chimeras circumvents the time consuming process of 
engineering distinct photocaged ligands for each receptor of interest. Many 
receptor ligands are large polypeptides, lipoproteins, or glycolipids, which 
present formidable design and synthesis problems.  By contrast, NVOC-
EMP1 is a small peptide that can be produced in large quantities via 
standard solid phase peptide chemistry.  
3.4 MATERIALS and METHODOLOGY: 
General Methods and Reagents. Erythropoietin was purchased from 
eBiosciences, nerve growth factor (NGF) and epidermal growth factor (EGF) 
from Invitrogen, and liposaccharide (LPS) from Sigma Aldrich. PCR primers 
and templates were purchased from Integrated DNA Technologies. Unless 
otherwise indicated, all expression plasmids were purchased from Addgene.  
Fmoc-protected amino acids were obtained from Merck Millipore, and all 
other chemicals used in solid phase peptide synthesis were purchased from 
Sigma Aldrich. Synthesis grade organic solvents were from Fisher Scientific. 
Peptide purification and small molecule purification were carried out using an 
HPLC system (Waters) outfitted with a C18 reversed phase column 
(VYDAC.) Mass spectrometry data was obtained by LC-MS (Agilent 
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Technologies) at the Memorial Sloan Kettering Cancer Center Mass 
Spectrometry Core Facility.  
 
Compound Synthesis and Purification. Fmoc-Tyr(NVOC)-OH was 
synthesized as described previously117. NVOC-EMP1 was synthesized by 
standard Fmoc Solid Phase Peptide Synthesis (SPPS) on Rink Amide resin. 
SPPS reactions were carried out in a custom-made glass peptide synthesis 
vessel (Adams & Chittenden). A constant stream of nitrogen was used to 
provide gentle agitation. Amino acid coupling was performed using HBTU as 
the carboxylic acid activating agent and DIPEA as the organic base in DMF 
solvent. For each coupling reaction: 3 eq of FMOC-AA-OH, 2.9 eq of HBTU 
and 3 eq of DIPEA were used. Coupling time was one hour at room 
temperature. Deprotection of FMOC was performed with 20% 
Piperidine/DMF for 20 minutes. The full sequence of NVOC-EMP1 is as 
follows: GGTY(NVOC) SCHF GPLT WVCK PQGG SSK(Biotin). Synthetic 
details are outlined in Supplemental Scheme 1. Assembled NVOC-EMP1 
was globally deprotected and cleaved from the resin using neat 
trifluoroacetic acid containing 5% water, 5% phenol, 5% thioanisole, and 
2.5% 1,2-ethanedithiol.  The peptide was then purified by HPLC using a 
water/acetonitrile gradient, yield: 10%. [M+H]3+ calculated for 
C125H180N32O37S3 was 940.083; found 940 (Fig. S1). Disulfide bond 
formation was induced by dissolving NVOC-EMP1 in 10% DMSO/phosphate 
buffered saline (PBS) and exposing the solution to air overnight. The folded  
peptide was subsequently stored at 40C in 10%DMSO/PBS.  
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Construction of Expression Plasmids. EpoR chimeras were constructed 
by fusing the extracellular and transmembrane domains of mouse EpoR 
(amino acids 1-271) to the intracellular domain of the receptor of interest via 
stitching PCR.  The EpoR-EGFR construct contains amino acids 668-1210 
of human EGFR; the EpoR-TrkA construct contains amino acids 441-799 of 
rat TrkA; the EpoR-TLR4 construct contains amino acids 625-835 of mouse 
TLR4.  cDNA encoding full-length rat TrkA was a gift from the Marc Tessier-
Lavigne lab (Rockefeller University). EpoR chimeras were cloned into the 
AgeI or BamHI sites of the lentiviral expression vector pRRL eGFP 
(Addgene) upstream of the GFP coding sequence. p65 cDNA was amplified 
via reverse-transcription from RNA extracted from B6 Mouse liver and 
cloned into pRRL RFP using the AgeI restriction site upstream of the RFP 
coding sequence. The pRRL RFP expression vector was modified from the 
parental pRRL eGFP by subcloning cDNA coding for the monomeric red-
fluorescence protein TagRFP-T into the AgeI and SalI sites.   
 
Cell Culture and Lentiviral Transduction. NIH-3T3 and RAW 264.7 (both 
from American Type Culture Collection) were maintained in complete DMEM 
supplemented with 10% fetal bovine serum (FBS) and antibiotics. PC12 cells 
(ATCC) were maintained in complete RPMI media supplemented with 10% 
Horse Serum, 5% FBS, and antibiotics. TF1 cells (ATCC) were maintained in 
complete RPMI media supplemented with 10% Horse Serum and 5% FBS, 
antibiotics and 2 ng/mL of human GM-CSF. Lentiviral transduction was 
carried out with second-generation lentiviral packaging plasmids psPAX2 
and pMD2.G (Addgene). HEK293HF cells (ATCC) at about 90% confluency 
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were transfected with the aforementioned lentiviral packaging plasmids by 
calcium phosphate method. Viral supernatants were collected after 48 hr at 
370C and were added to 50% confluent NIH-3T3 and RAW 264.7 cells or to 
2 million PC12 cells in suspension. Mixtures were subsequently centrifuged 
at 1000 × g in the presence of polybrene (4 μg/mL) at 350C for 1 hr and 
allowed to incubate overnight at 370C.  Cells were then expanded in fresh 
medium. 
 
Biochemical Assays/Western Blotting. Approximately 2×105 cultured cells 
were used for each gel sample in signaling experiments.  NVOC-EMP1 was 
decaged by UV irradiation on ice for 45 minutes using a handheld lamp 
outfitted with a 6 Watt 350 nm light source. Prior to ligand stimulation, 
cultured cells were starved of serum and other growth factors for two hours.  
After ligand treatment, cells were lysed in cold cell lysis buffer containing 10 
mM TrisHCl, pH 7.4, 5 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 
and 0.15 M NaCl. Samples were then analyzed by western blot using the 
following antibodies: P-Erk1/2 (P-Thr202/Tyr204; clone 20G11; Cell 
Signaling Technology), P-EGFR (P-Tyr 1068; clone 2234; Cell Signaling 
Technology), IκBα (clone 9242; Cell Signaling Technology), actin (clone 
AC40; Sigma Aldrich), mouse IgG HRP-linked (clone 7076, Cell Signaling 
Technology), rabbit IgG HRP-linked (clone 7074; Cell Signaling Technology). 
Each antibody was used at the manufacturer’s recommended dilution.   
 
Neuronal Differentiation Assay. Actively dividing PC12 cells were treated 
with trypsin for 15 min at 370C to create single cell suspensions. Cells were 
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then plated onto 24-well tissue culture plates (1x104 per well) that had been 
previously coated with 40 μg/ml of rat tail collagen Type I (Sigma Aldrich) in 
RPMI supplemented with 2.5% horse serum. NGF, Epo, or NVOC-EMP1 
was added at desired concentrations and cells were allowed to incubate for 
3 days at 370C before imaging analysis.   
 
Photoactivation and Fluorescence Microscopy Experiments. Glass 
surfaces for photoactivation were prepared from eight-well chamber slides 
(Nunc). Chamber slides were coated with biotinylated poly-L-lysine 
(produced with NHS-biotin, Pierce Biotechnology), washed with H2O, and 
allowed to dry overnight. They were then incubated with streptavidin (100 
μg/mL in PBS) for at least 1 hr. After washing with PBS, the surfaces were 
incubated in the desired concentration of biotinylated NVOC-EMP1 for 1 hr 
in PBS. They were washed again and left in PBS until use. RAW 264.7 cells 
were allowed to adhere to coated chamber slides for 10 min at 370C before 
data collection. Live imaging experiments were carried out using an inverted 
fluorescence video microscope fitted with either a 40 × objective lens or 150 
× TIRF objective lens (Olympus).  Lasers at 488 nm and 561 nm (Melles 
Griot) were used for imaging of GFP and TagRFP-T, respectively. A Mosaic 
digital diaphragm apparatus (Photonic Instruments) attached to a mercury 
(HBO) lamp (serial number: Ushio USH-102DH, 100 Watts, 20 Volts) was 
used for photoactivation. The approximate UV intensity given the microscope 
set up in our laboratory is 1 mW/cm2. Time-lapse recordings were made with 
Slidebook software (Intelligent Imaging Innovations). For p65 nuclear 
localization experiments, images were acquired every 20 s. For TIRF 
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photoactivation experiments, images were acquired every 3 s. Cells were 
activated with a UV exposure of 3-5 s.  
 
Image Analysis. Nuclear localization of P65 was quantified ratiometrically 
by determining the average p65-RFP fluorescence intensity in the nucleus at 
each time point and dividing this by the p65-RFP fluorescence intensity of a 
corresponding region in the cytosol.  EpoR-TLR4-GFP accumulates in 
perinuclear compartments as well as the cell membrane, enabling 
straightforward identification of the nucleus in the GFP channel as a central 
region devoid of GFP fluorescence. EpoR-TLR4-GFP clustering was 
quantified by determining the mean fluorescence intensity of the cell footprint 
inside and outside of the irradiated region as a function of time.  Image 
analysis was performed using Slidebook, Microsoft Excel, and GraphPad 
Prism.  
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CONCLUSIONS 
The two technologies described in this thesis have much potential to be 
expanded upon as video-microscopy platforms to study polarized signal 
transduction. 
As discussed in chapter 1, current light-gated approaches to activate cell 
surface receptors rely on the intracellular expression of light sensitive 
proteins, which can diffuse to other parts of the cell after photo-stimulation.  
Because NVOC-EMP1 can be immobilized outside of the cell, it provides a 
more straightforward avenue for the induction of signaling that is both 
sustained and spatially constrained.  We anticipate that this property will be 
very useful for the study of signaling systems that provide directional 
information. Axon guidance, for example, is mediated by cell surface 
receptors that translate environmental cues into turning behavior; attractive 
factors induce polarized cytoskeletal outgrowth toward them, while repulsive 
factors cause localized cytoskeletal collapse and retraction94.  Because 
these responses can take up to an hour to manifest, an experimental system 
that maintains polarity over this timescale will presumably be critical for 
detailed mechanistic analyses.  The NVOC-EMP1 platform should also be 
useful for studying receptors that function in multiple cellular compartments.  
TLR4, for instance, transduces qualitatively different signals depending on 
whether it is activated at the plasma membrane or in endosomes118.  By 
selectively targeting receptors on the plasma membrane, our approach will 
enable investigators to delineate these two branches of the signaling 
cascade 
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The NVOC-EMP1 platform suffers from a few drawbacks. The most obvious 
is associated with the use of chimeric receptors. Replacing the extracellular 
domain of a receptor with that of another poses the risk that some, if not all 
functionalities, of the original receptor will be negatively affected. We indeed 
saw such effects on CSF1R, a type I trans-membrane receptor tyrosine 
kinase important for macrophage differentiation and chemotaxis. The EpoR-
CSF1R chimeric receptor only recapitulates some of the signaling circuits 
downstream of CSF1R activation (Data not shown). It is therefore necessary 
to fully test the functionality of EpoR-chimeric receptors. 
Another potential drawback stems from the use of EpoR as the parent 
receptor from which chimeras are derived.  We chose to work with EpoR for 
the reason that it is one of the better-characterized receptors. Furthermore, 
that EMP1, a small peptide, had been developed as a functional mimic of the 
full length Epo ligand, simplified the design of a caged agonist. Our strategy 
rests on the assumption that EpoR is a specialized receptor whose 
expression is limited to cells in the erythroid lineage. While EpoR expression 
is mostly absent in epithelial and cancer cell lines (NIH3T3, HEK293T and 
RAW 264.7), EpoR has recently been shown to be expressed in cells of the 
myeloid and lymphoid lineage119.  Expression of EpoR-chimeric receptors in 
cells expressing endogenous EpoR could prove to be problematic, especially 
if the endogenous EpoR signaling interferes with that of the EpoR-chimeric 
receptor. Recent advances in genome editing technologies, such as 
CRISPR, provide a work-around. Endogenous EpoR could be deleted in the 
genome of the cell of interest where necessary.  
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NVOC-EMP1 is the first universal ligand platform of its kind to activate cell 
surface receptors in a light-dependent manner. Looking forward, the system 
holds tremendous promise for detailed mechanistic studies of cell surface 
receptor signaling at high spatiotemporal resolution. Given the need to 
create chimeras, there are a few key considerations in the selection of cell 
surface receptors that are to be studied using the NVOC-EMP1 platform. 
From a functional perspective, as has been discussed above, EPOR-
chimeric receptors are not guaranteed to be fully functional and extensive 
testing therefore is necessary to validate the functionality of chimeras of 
interest. To increase the likelihood of creating fully functional EPOR-
chimeras, receptors that share similar structural and activation features to 
those of EPOR would be good candidates. As EPOR belongs to the cytokine 
receptor family, cytokine receptors would likely form functional EPOR-
chimeras. Indeed, a fully functional chimeric receptor consisting of the 
extracellular domain of EPOR and transmembrane and intracellular domains 
of IFN-γ has been previously described120. Receptor tyrosine kinases, whose 
activation mechanism relies on ligand-induced dimerization of homodimer 
receptors, should in theory be good candidates for EPOR-chimeras. Indeed, 
functional EPOR chimeras of EGFR (described in chapter 3) and stem cell 
factor (SCF) receptor have been successfully created103.  CSF1R as 
previously discussed is a noteworthy exception, which once again highlights 
the need to extensively test EPOR-chimeras for functionality.  
The other consideration when selecting receptors for investigation using the 
NVOC-EMP1 platform takes into account the biological significance of the 
associated downstream signaling. The NVOC-EMP1 system was designed 
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to provide a means to control activation of cell surface receptors in a 
spatiotemporal specific manner. Such precise control is uniquely suited for 
the analysis of polarized signal transduction from cell surface receptors. 
Receptors with known polarized signal transduction such as TrkA are 
therefore attractive candidates. Other receptors, such as TLR4 whose 
signaling dynamics upon activation remain incompletely understood, yet 
might be implicated in polarized signal transduction, are also attractive 
candidates for further investigation using the NVOC-EMP1 platform.  
Devoid of all the drawbacks associated with use of EPOR-chimeric 
receptors, the photoactivatable SDF1α system makes use of a native ligand 
to activate an endogenously expressed receptor. Current light-gated 
technologies to control chemokine receptor activation require cellular 
expression of a light sensitive chimeric GPCR45,46. Since primary cells such 
as stem cells and neutrophils are notoriously difficult to manipulate 
genetically without altering their stemness or activation status respectively, 
the use of a native light-gated ligand capable of activating endogenous 
receptor is therefore a tremendous advantage.  
That NVOC-SDF1α is a native ligand also facilitates the extension of the 
system to in vivo studies. For example, SDF1α has long been appreciated as 
a key chemokine that mediates the recruitment of CXCR4 positive tumor 
promoting macrophages (TAMs) into the tumor microenvironment. The 
chemokine was also shown to be important in the recruitment of endothelial 
progenitors which promote tumor angiogenesis121. Caged SDF1α provides a 
means to study such recruitment dynamics in the tumor microenvironment 
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with spatial and temporal resolution. Since the caged chemokine is inactive 
until photo-activated, it can be delivered to the tumor sites via the circulatory 
system or direct injection into the tumors. Modification of the caging group 
would have to be made to accommodate for two-photon de-caging, but in 
principle, the caged chemokine would serve as a useful tool to study the 
recruitment dynamics of a wide range of cell types in the tumor 
microenvironment.  
NVOC-SDF1α highlights the central role that the unstructured N-terminal 
domain plays in the functionality of the full protein and how such a structural 
property could be exploited to create a photo-caged ligand. Interestingly, 
SDF1α or CXCL12 is not the only chemokine to contain such unique 
functionality within the N-terminal residues. Studies of the chemokines 
CCL2, CCL5, CCL19, and CXCL10  have all revealed a critical role  for the 
N-terminal residues in controlling the chemokines’ agonist activity18. This 
structural feature then provides a general strategy to generate caged 
chemokines. Indeed, as this thesis was being written, a photoactivatable 
CCL5 chemokine was generated by photo-caging key residues in the 
chemokine’s N-terminal domain122. That caged chemokines can be 
generated with relative ease using a common strategy (i.e.: photo-caging the 
N-terminal domain) holds great promise for mechanistic studies of the 
biology of chemokines and chemokine receptors.  
Biological processes harbor tremendous complexity. For example, as 
discussed at length in the previous chapters of this thesis, a single event of 
ligand binding to a cell surface receptor triggers a plethora of downstream 
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reactions and enzymatic circuits that often interact with each other in space 
and time to drive cellular events. Such complexity renders the study of 
biology one that relies heavily on advances in technology that allow for 
careful measurements to be made. This thesis described two attempts to 
provide biologists with tools to make careful and quantitative observations 
from which biological processes could be better understood.  
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